+ Translate
+ Most Popular
Advantages and disadvantages of bordeaux mixture and of lime-sulphur used on apples in the growing season
Observations on the Umaria marine bed
10 years of hearing conservation in the Royal Air Force
Chocolate crumb - dairy ingredient for milk chocolate
Effect of daily gelatin ingestion on human scalp hair
Comparison of rice bran and maize bran as feeds for growing and fattening pigs
The composition of pampas-grass (Cortaderia argentea.)
The Accraian Series:
The mechanism of the Liebermann-Burchard reaction of sterols and triterpenes and their esters
Cerebrovascular Doppler ultrasound studies (cv-Doppler)
Toria: PT-303 - first national variety
Hair growth promoting activity of tridax procumbens
Productivity of Pekin x Khaki Campbell ducks
A stable cytosolic expression of VH antibody fragment directed against PVY NIa protein in transgenic potato plant confers partial protection against the virus
Solar treatment of wheat loose smut
Swimmers itch in the Lake of Garda
Bactofugation and the Bactotherm process
The effects of prefrontal lobotomy on aggressive behavior in dogs
Visual rating scales for screening whorl-stage corn for resistance to fall armyworm
Breakdown of seamounts at the trench axis, viewed from gravity anomaly
Kooken; pennsylvania's toughest cave
Recovery of new dinosaur and other fossils from the Early Cretaceous Arundel Clay facies (Potomac Group) of central Maryland, U.S.A
Zubor horny (Bison bonasus) v prirodnych podmienkach Slovensku
The extended Widal test in the diagnosis of fevers due to Salmonella infection
Hair of the american mastodon indicates an adaptation to a semi aquatic habitat

List of PDF Full Texts available from EurekaMag Chapter 67148

Chapter 67148 contains a list of PDF Full Texts available from EurekaMag.

A422 Outcomes of Stem Cell Transplantation for Myeloma in Thailand
, Clinical Lymphoma and Myeloma 9: S66-S67 (2009)

A432 Long-Term Treatment with Lenalidomide in Previously Treated Subjects with Multiple Myeloma
, Clinical Lymphoma and Myeloma 9: S68-S69 (2009)

A435 Dex/Thal as Induction and Maintenance Treatment in Elderly Patients with Mm: A Randomized Trial
, Clinical Lymphoma and Myeloma 9: S69-S70 (2009)

A448 Intermittent Dex/Thal as Pretransplantation and Maintenance Treatment in De Novo Mm: A Randomized Trial
, Clinical Lymphoma and Myeloma 9: S71-S72 (2009)

A450 Alternating Vamp/ThaCyDex: An Effective Salvage Regimen in Relapsed Multiple Myeloma Patients
, Clinical Lymphoma and Myeloma 9: S72-S73 (2009)

A453 Total Marrow Irradiation, Busulfan, and Cyclophosphamide Is Equivalent to Tandem Melphalan in Myeloma
, Clinical Lymphoma and Myeloma 9: S73-S74 (2009)

A470 Phase Ii Trial of Mel/Dex + Bortezomib for Al Amyloidosis
, Clinical Lymphoma and Myeloma 9: S74-S75 (2009)

A474 Single-Agent Cytarabine Effectively Mobilizes Stem Cells in Heavily Pretreated Myeloma Patients
, Clinical Lymphoma and Myeloma 9: S75-S76 (2009)

A481 Long-Term Results of Single-Agent Thalidomide as Initial Therapy for Smoldering or Indolent Myeloma
, Clinical Lymphoma and Myeloma 9: S76-S77 (2009)

A498 Thalidomide + Dexamethasone After Asct Improves Pfs in Mm: A Brazilian Randomized Trial
, Clinical Lymphoma and Myeloma 9: S78-S79 (2009)

A508 Treatment Response and Survival in Myeloma Renal Failure
, Clinical Lymphoma and Myeloma 9: S79-S80 (2009)

A518 Dendritic cells Immunotherapy: A Phase Ii Clinical Trial
, Clinical Lymphoma and Myeloma 9: S80-S81 (2009)

A530 Characterization of Bortezomib Resistance in Multiple Myeloma Cell Lines
, Clinical Lymphoma and Myeloma 9: S81-S82 (2009)

A533 Rad001: Phase Ii Trial in Relapsed/Refractory Waldenstrm Macroglobulinemia, the Dfci Experience
, Clinical Lymphoma and Myeloma 9: S82-S83 (2009)

A535 Phase Ii Trial of Bortezomib and Rituximab in Relapsed/Refractory Waldenstrm Macroglobulinemia
, Clinical Lymphoma and Myeloma 9: S83-S84 (2009)

A546 Mrc Myeloma Ix: Preliminary Results from The Intensive Pathway Study
, Clinical Lymphoma and Myeloma 9: S84-S85 (2009)

A574 Generic Bortezomib-Induced Severe Peripheral Neuropathy in Newly Diagnosed Multiple Myeloma Patients
, Clinical Lymphoma and Myeloma 9: S86-S87 (2009)

A586 A Slow Pattern of Response in a Relapsed Multiple Myeloma Patient Treated with Lenalidomide
, Clinical Lymphoma and Myeloma 9: S88-S89 (2009)

A609 Extended Follow-up Results of BiRd Therapy: Prolonged Responses Achieved
, Clinical Lymphoma and Myeloma 9: S89-S90 (2009)

A618 Non-Frozen Autologous Peripheral Blood Stem Cells Transplantation in Multiple Myeloma
, Clinical Lymphoma and Myeloma 9: S91-S92 (2009)

A628 MicroRna Profile Identifies Distinct Clinically Relevant Subgroups in Multiple Myeloma
, Clinical Lymphoma and Myeloma 9: S93-S94 (2009)

B026 Cs1 Promotes Multiple Myeloma Cell Adhesion, Clonogenic Growth, and Tumorigenicity via c-Maf Mediation
, Clinical Lymphoma and Myeloma 9: S96-S97 (2009)

B033 Aurora-Kinase Inhibition for Tailored Risk-Adapted Treatment of Multiple Myeloma
, Clinical Lymphoma and Myeloma 9: S97-S98 (2009)

B037 Cal-101: A Selective Inhibitor of Pi3K p110D for the Treatment of Multiple Myeloma
, Clinical Lymphoma and Myeloma 9: S98-S99 (2009)

B050 Angiogenesis in Multiple Myeloma: Induction by Normal Plasma Cell and Aberrantly Expressed Genes
, Clinical Lymphoma and Myeloma 9: S99-S100 (2009)

B081 Hevylite Detects Residual IgGk in IgG Heavy-chain Disease
, Clinical Lymphoma and Myeloma 9: S100-S101 (2009)

B101 Quantification of Polymerising Serum Free Light Chains
, Clinical Lymphoma and Myeloma 9: S101-S102 (2009)

B106 MicroRna Expression Profiling in Multiple Myeloma: Correlation with Genetic Abnormalities
, Clinical Lymphoma and Myeloma 9: S102-S103 (2009)

B137 Pharmacogenetic Modeling for Prediction of Patient Outcomes in Myeloma
, Clinical Lymphoma and Myeloma 9: S103-S104 (2009)

B145 Bmsc-induced Drug Resistance by Arresting Mm Cells at First Contact
, Clinical Lymphoma and Myeloma 9: S104-S105 (2009)

B152 First Analysis of Hovon-65/Gmmg-Hd4 Randomized Phase Iii Trial Comparing Bortezomib, Doxorubicin, Dexamethasone (Pad) vs. Vad as Induction Treatment Prior to High-dose Melphalan (Hdm) in Patients with Newly Diagnosed Multiple Myeloma (Mm)
, Clinical Lymphoma and Myeloma 9: S105-S106 (2009)

B168 April Induces Proliferation of Primary Myeloma Cells Expressing Cyclin D2
, Clinical Lymphoma and Myeloma 9: S106-S107 (2009)

B176 Acquisition of a Multidrug Resistant Phenotype with a Proteasome Inhibitor
, Clinical Lymphoma and Myeloma 9: S107-S108 (2009)

B195 Dna Dsbs Induction by Zalypsis, a Novel Marine Compound, Results in Potent Antimyeloma Activity
, Clinical Lymphoma and Myeloma 9: S109-S110 (2009)

B200 Targeted Drug Combinations in Poor Prognosis Multiple Myeloma: Therapeutic Implications
, Clinical Lymphoma and Myeloma 9: S110-S111 (2009)

B207 In the Crosshairs: Targeting Myeloma Cd28-B7 Interactions
, Clinical Lymphoma and Myeloma 9: S112-S113 (2009)

B213 Integrin-linked Kinase as a Target in Multiple Myeloma
, Clinical Lymphoma and Myeloma 9: S113-S114 (2009)

B216 Probing the Stem Cell in the 5T33 Multiple Myeloma Model
, Clinical Lymphoma and Myeloma 9: S114-S115 (2009)

B226 High Hgf Levels are Associated with Response to Bortezomib
, Clinical Lymphoma and Myeloma 9: S115-S116 (2009)

B234 Dasatinib and Dexamethasone Combination Therapy Targets Myeloma and the Tumor Microenvironment
, Clinical Lymphoma and Myeloma 9: S116-S117 (2009)

B257 Vorinostat in Combination with Other Anti-Mm Agents
, Clinical Lymphoma and Myeloma 9: S117-S118 (2009)

B267 Mek/Erk and Mevalonate Pathways Inhibition in Multiple Myeloma
, Clinical Lymphoma and Myeloma 9: S118-S119 (2009)

B279 Panel of Potential Proteomic Biomarkers for Predicting Response to Thalidomide in Multiple Myeloma
, Clinical Lymphoma and Myeloma 9: S119-S120 (2009)

B304 Does Toll-like Receptor 9 Signaling Play a Role in Myeloma Disease Progression?
, Clinical Lymphoma and Myeloma 9: S121-S122 (2009)

B325 Immune Dysregulation in Mgus: Evidence that Mgus Is Not an Immunologically Inert State
, Clinical Lymphoma and Myeloma 9: S123-S124 (2009)

B340 Molecular Classification of Newly Diagnosed Mm Patients Included in a Prospective Phase Iii Trial
, Clinical Lymphoma and Myeloma 9: S124-S125 (2009)

B350 Sns-032, a Potent and Selective Cdk2, 7 and 9 Inhibitor, Demonstrates Preclinical Activity in Human Multiple Myeloma
, Clinical Lymphoma and Myeloma 9: S125-S126 (2009)

B357 Targeting Myeloma Bone Disease via Activin A Inhibition
, Clinical Lymphoma and Myeloma 9: S126-S127 (2009)

B365 Molecular Cytogenetic Analysis of Waldenstrm Macroglobulinemia in Korea
, Clinical Lymphoma and Myeloma 9: S127-S128 (2009)

B373 Frequency of Abnormal Serum Free Light-Chain Ratio in a French Cohort of Patients with Mgus
, Clinical Lymphoma and Myeloma 9: S128-S129 (2009)

B387 Studies on c-Kit Protein Expression and c-Kit Gene in Mm Patients
, Clinical Lymphoma and Myeloma 9: S129-S130 (2009)

B398 Suggestion of a Tool for Assessment of Plasma Cells in the Bone Marrow of Myeloma Patients
, Clinical Lymphoma and Myeloma 9: S131-S132 (2009)

B405 Association of Genetic Variants with Fish-Based Karyotyping Status in Multiple Myeloma Patients
, Clinical Lymphoma and Myeloma 9: S132-S133 (2009)

B414 Genes Mage-C1 and Mage-A3 Are Central to the Survival and Chemotherapy-Resistance of Myeloma Cells
, Clinical Lymphoma and Myeloma 9: S133-S134 (2009)

B434 Hgf Inhibited Osteoblatogenenesis Via Regulation of Opn Mediated Mapk and Nf-kB Pathways in Mm
, Clinical Lymphoma and Myeloma 9: S134-S135 (2009)

B446 Nk Cell Mediated Immunologic Responses Against Myeloma by B7-1(Cd80)/Il-2 Immune Gene Therapy
, Clinical Lymphoma and Myeloma 9: S135-S136 (2009)

B457 At7519, a Multi-Cyclin Dependent Kinase Inhibitor, Induces Apoptosis in Multiple Myeloma via Gsk3B
, Clinical Lymphoma and Myeloma 9: S137-S138 (2009)

B469 Unraveling the Synergism of Nab-Rapamycin and Perifosine Combination in Multiple Myeloma
, Clinical Lymphoma and Myeloma 9: S138-S139 (2009)

B483 A Novel Small-Molecule Inhibitor Rgb 286638 Induces Apoptosis and Necrosis in Multiple Myeloma
, Clinical Lymphoma and Myeloma 9: S139-S140 (2009)

B494 Quantitative Protein Expression-Based Classification of Mm
, Clinical Lymphoma and Myeloma 9: S140-S141 (2009)

B507 Lethal and Bortezomib-Sensitizing Targets in Myeloma Identified by Genome-Scale Rnai Screening
, Clinical Lymphoma and Myeloma 9: S141-S142 (2009)

B516 Nt-proBnp Levels in Myeloma Patients Without Evidence of Amyloidosis
, Clinical Lymphoma and Myeloma 9: S142-S143 (2009)

B525 Regulation of Histone Deacetylase in Waldenstrm Macroglobulinemia
, Clinical Lymphoma and Myeloma 9: S143-S144 (2009)

B528 Dual Pi3K and mTor Inhibition in Waldenstrm Macroglobulinemia
, Clinical Lymphoma and Myeloma 9: S144-S145 (2009)

B538 In Vivo Imaging Model of Multiple Myeloma and its Cellular Interaction with the Bone Marrow Milieu
, Clinical Lymphoma and Myeloma 9: S145-S146 (2009)

B540 The Effect of Insulin-Like Growth Factor-1 in Waldenstrm Macroglobulinemia
, Clinical Lymphoma and Myeloma 9: S146-S147 (2009)

B552 the European Myeloma Stem cell Network (Mscnet)
, Clinical Lymphoma and Myeloma 9: S147-S148 (2009)

B555 Prognostic Value of Free and Heavy/Light Chain Analysis
, Clinical Lymphoma and Myeloma 9: S148-S149 (2009)

B562 Increasing Numbers of Most Mature Peripheral Blood B-Subsets are Observed in Monoclonal Gammopathies
, Clinical Lymphoma and Myeloma 9: S150-S151 (2009)

B564 Various Growth Factors Regulate Mesenchymal Stem cell Differentiation Derived Human Multiple Myeloma
, Clinical Lymphoma and Myeloma 9: S151-S152 (2009)

B581 MicroRna Regulate Growth and Angiogenesis in Multiple Myeloma
, Clinical Lymphoma and Myeloma 9: S153-S154 (2009)

B587 A Novel Genetic Polymorphism in the Dna Polymerase Kappa Gene May Play a Role in Multiple Myeloma
, Clinical Lymphoma and Myeloma 9: S154-S155 (2009)

B596 Immunoglobulin Ratios: An Alternative to Immunofixation
, Clinical Lymphoma and Myeloma 9: S156-S157 (2009)

B601 aCgh in Vk*Myc Mice Identifies Genetic Changes Shared with Human Mm
, Clinical Lymphoma and Myeloma 9: S157-S158 (2009)

B615 The Role of Rtk's in Waldenstrm Macroglobulinemia
, Clinical Lymphoma and Myeloma 9: S158-S159 (2009)

Differentiation of highly prevalent Is6110 single-copy strains of Mycobacterium tuberculosis from a rural community in South India with an ongoing Dots programme
, Infection, Genetics and Evolution 5(1): 67-77 (2005)

Left atrial volume: an important prognostic factor in patients with heart failure and left ventricular systolic dysfunction
, European Journal of Heart Failure Suppls 6(1): 156-157 (2007)

Effects of Darbepoetin-alpha on quality of life and emotional stress in anemic patients with chronic heart failure
, European Journal of Heart Failure Supplements 7: 26-27 (2008 )

The Home-Hf Study: A multi-centre randomised controlled trial of home telemonitoring in a general heart failure population of elderly patients with co-morbidity
, European Journal of Heart Failure Supplements 7: 152-153 (2008)

Lipid-lowering translating evidence into benefits
, Atherosclerosis Suppls 2(4): 1-3 (2002)

Replacement of dietary saturated fat with trans fat reduces serum paraoxonase activity in healthy men and women
, Atherosclerosis Suppls 2(2): 110-111 (2001)

Hdl in risk prediction and its direct and indirect involvement in atherogenesis
, Atherosclerosis Suppls 3(4): 3-12 (2002)

The next step in cardiovascular protection
, Atherosclerosis Suppls 4(5): 3-9 (2003)

Long-term statin safety and efficacy in secondary prevention: can combination therapy improve outcomes?
, Atherosclerosis Suppls 4(5): 11-16 (2003)

Preventing the next event in the elderly: the Prosper perspective
, Atherosclerosis Suppls 4(5): 17-22 (2003)

0Soa02-2 Seeing is believing: Imaging techniques to measure atherosclerosis progression
, Atherosclerosis Suppls 4(2): 1-2 (2003)

1Sy01-5 Nuclear receptors as the body's lipid sensors
, Atherosclerosis Suppls 4(2): 3-4 (2003)

1Fs01-6 Nurture vs nature in diabetic vasculopathy: Roles of advanced glycation endproducts and the receptor for them
, Atherosclerosis Suppls 4(2): 5-6 (2003)

1Fs02-4 Diet, physical activity, childhood obesity and risk of cardiovascular disease
, Atherosclerosis Suppls 4(2): 6-7 (2003)

1Fs03-3 Global guidelines: National issues
, Atherosclerosis Suppls 4(2): 7-8 (2003)

1Soa03-5 Field: Where do we stand? Significant lipid changes in a large-scale trial of fenofibrate to prevent cardiovascular disease in type 2 diabetes
, Atherosclerosis Suppls 4(2): 10-11 (2003)

1Ws02-5 Gene expression and plaque instability
, Atherosclerosis Suppls 4(2): 13-14 (2003)

1Ws03-5 Recycling of apoprotein E promotes cholesterol-efflux and generation of Hdl-E
, Atherosclerosis Suppls 4(2): 14-15 (2003)

1P-0004 Sternal microcirculation after harvesting of the left internal mammary artery
, Atherosclerosis Suppls 4(2): 19-20 (2003)

1P-0009 Estrogen attenuates fatty strak formation in coronary arteries in cholesterol-fed diabetic male rabbits
, Atherosclerosis Suppls 4(2): 20-21 (2003)

1P-0023 Amount of thrombus at culprit lesion of acute myocardial infarction is dependent on angioscopically determined coronary atherosclerosis
, Atherosclerosis Suppls 4(2): 23-24 (2003)

1P-0027 Significance of small dense low-density lipoprotein phenotype and other risk factors in patients with various types of coronary heart diseases
, Atherosclerosis Suppls 4(2): 24-25 (2003)

1P-0057 Polymorphisms C(-1562)T in the promoter of the matrix metalloproteinase-9 (Mmp-9), C677T of methylenetetrahydrofolate reductase (Mther), G298T of endothelial nitric oxide synthase (Enos), G455A of B-fibrinogen (B Fb) genes and coronary arteriosclerosis
, Atherosclerosis Suppls 4(2): 31-32 (2003)

1P-0061 Findings from autopsy in (sudden) cardiac death
, Atherosclerosis Suppls 4(2): 32-33 (2003)

1P-0066 Severity of coronary arterial stenotic changes correlates with increases in plasma insulin and plasminogen activator inhibitor 1 levels in patients with type 2 diabetes
, Atherosclerosis Suppls 4(2): 33-34 (2003)

1P-0070 Coronary flow velocity reserve is reduced in pre-menopausal patients with systemic lupus erythematosus
, Atherosclerosis Suppls 4(2): 34-35 (2003)

1P-0079 A comparative study of prevalence of hypertension and body mass index in urban and rural areas of Tehran
, Atherosclerosis Suppls 4(2): 36-37 (2003)

1P-0088 Four blood pressure indexes and the long-term risk of stroke in Japanese men and women: The Oyabe study
, Atherosclerosis Suppls 4(2): 38-39 (2003)

1P-0097 The relationships between fibrinogen, plasminogen activator inhibitor-1 and their gene polymorphisms in patients with essential hypertension
, Atherosclerosis Suppls 4(2): 40-41 (2003)

1P-0110 Dyslipidaemia and hypertension as aspects of metabolic syndrome X. Is the management sufficient?
, Atherosclerosis Suppls 4(2): 43-44 (2003)

1P-0118 Single nucleotide polymorphism (-469 G to A) at the promoter region of sterol regulatory element binding protein-1c associates with hypertriglyceridemia induced by a diet high in fructose in mice
, Atherosclerosis Suppls 4(2): 45-46 (2003)

1P-0122 Body mass index, heart rate variability, and haptoglobin polymorphism in patients with coronary artery disease
, Atherosclerosis Suppls 4(2): 46-47 (2003)

1P-0131 Genetic and structural evaluation of fatty acid transport protein-4 (Fatp4) in relation to markers of the insulin resistance syndrome
, Atherosclerosis Suppls 4(2): 48-49 (2003)

1P-0136 Effect of pioglitazone on atherogenic outcomes in patients with type 2 diabetes: Comparison with responder and non-responder groups
, Atherosclerosis Suppls 4(2): 49-50 (2003)

1P-0145 Impact of diabetes mellitus on initial and long-term clinical results of long coronary lesions: Multicenter registry in Japan
, Atherosclerosis Suppls 4(2): 51-52 (2003)

1P-0154 Angiotensin Ii plays as a survival factor in the retinal endothelial cells through type 1 receptor and Pi 3-kinase-Akt pathway
, Atherosclerosis Suppls 4(2): 53-54 (2003)

1P-0171 Hsp70 or Hsp27 overexpressed in endothelial cells during post-ischemic reperfusion may protect from delayed apoptosis
, Atherosclerosis Suppls 4(2): 57-58 (2003)

1P-0176 Peripheral biological clock regulates circadian gene expression in vascular endothelial cells
, Atherosclerosis Suppls 4(2): 58-59 (2003)

1P-0180 High glucose upregulates plasminogen activator inhibitor-1 (Pai-1) expression through activation of apoptosis signal-regulating kinase 1 (Ask1) in endothelial cells
, Atherosclerosis Suppls 4(2): 59-60 (2003)

1P-0186 Shear flow attenuates interleukin-6-induced Stat3 activation in endothelial cells
, Atherosclerosis Suppls 4(2): 60-61 (2003)

1P-0196 The Pdgf-B retention motif knockout mouse shows primary conduit vessel and renaldysfunction together with eccentric cardiac hypertrophy
, Atherosclerosis Suppls 4(2): 62-63 (2003)

1P-0201 Local therapy with control-released basic fibroblast growth factor (bFgf) in the cardiac field
, Atherosclerosis Suppls 4(2): 63-64 (2003)

1P-0205 Functional analysis about the role of Smad3-dependent transforming growth factor- signaling in neointimal hyperplasia
, Atherosclerosis Suppls 4(2): 64-65 (2003)

1P-0210 Effects of endogenous placental growth factor on vascular permeability in pathological conditions
, Atherosclerosis Suppls 4(2): 65-66 (2003)

1P-0219 Selective uptake of Hdl-associated cholesterolesters (Ce) by mouse peritoneal macrophages independent from scavenger receptor class B type (Sr-Bi)
, Atherosclerosis Suppls 4(2): 67-68 (2003)

1P-0228 A quantitative trait locus on chromosome 10p11 influences variation in plasma Hdl-C levels in Finnish dyslipidemic families
, Atherosclerosis Suppls 4(2): 69-70 (2003)

1P-0232 Apolipoprotein A-I-mediated secretion of apolipoprotein E has structural requirements distinct from those related to stimulation of cholesterol efflux
, Atherosclerosis Suppls 4(2): 70-71 (2003)

1P-0236 Relationship between Helicobacter pylori, ischemic colitis and arterial stiffness
, Atherosclerosis Suppls 4(2): 71-72 (2003)

1P-0241 Association between chronic Helicobacter pylori infection and ischemic stroke
, Atherosclerosis Suppls 4(2): 72-73 (2003)

1P-0256 Role of lysosomal cathepsin in 7-oxysterol induced apoptosis
, Atherosclerosis Suppls 4(2): 75-76 (2003)

1P-0265 Role of monocyte-macrophage in atherosclerosis in thromboxane A2 receptor-deficient mice
, Atherosclerosis Suppls 4(2): 77-78 (2003)

1P-0269 Defibrase restored endothelial nitric oxide-mediated vasorelaxation in an atherosclerotic rabbit model
, Atherosclerosis Suppls 4(2): 78-79 (2003)

1P-0274 Narmp 1 expressed in atherosclerotic lesions may be associated with 7-oxysterol induced apoptosis
, Atherosclerosis Suppls 4(2): 79-80 (2003)

1P-0288 Effects of -tocopherol and astaxanthin on plaque composition in atheroma of hyperlipidaemic rabbits
, Atherosclerosis Suppls 4(2): 82-83 (2003)

1P-0292 Vitamin E can reduce blood pressure in mild hypertensives
, Atherosclerosis Suppls 4(2): 83-84 (2003)

1P-0302 Importance of the serum levels of lipoprotein (a) in determining the risk of ischemic heart disease in longtime vegetarians
, Atherosclerosis Suppls 4(2): 85-86 (2003)

2Ws07-16 Granulocyte coloby-stimulating factor as a novel and non-invasive regeneration therapy against intractable arteriosclerosis obliterans and coronary heart disease
, Atherosclerosis Suppls 4(2): 95-96 (2003)

2Ws08-5 Significance of insulin resistance to atherosclerosis
, Atherosclerosis Suppls 4(2): 96-97 (2003)

2Ws09-5 Homocysteine as a risk factor of cardiovascular disease
, Atherosclerosis Suppls 4(2): 97-98 (2003)

2Ws10-5 ApoE trapping: Is increased Ldlr always good for us?
, Atherosclerosis Suppls 4(2): 98-99 (2003)

2Ws12-4 Blockade of Tgf- by catheter-based gene transfer of a soluble Tgf- type Ii receptor inhibits in-stent neointima by decreased extracellular matrix accumulation and deposited proportionally more collagen in neointima
, Atherosclerosis Suppls 4(2): 100-101 (2003)

2Ht02-1 Adhesion molecules related with homing of endothelial progenitor cells and induction of homing by expression of the molecules by gene transfer
, Atherosclerosis Suppls 4(2): 105-106 (2003)

2P-0322 Characteristics of lipid status of healthy young persons in Vojvodina
, Atherosclerosis Suppls 4(2): 108-109 (2003)

2P-0326 Individual Cvd global risk and general practitioners management in Warsaw Monica Bis study
, Atherosclerosis Suppls 4(2): 109-110 (2003)

2P-0335 An epidemiological study about regularity of sex hormone changes in men and effects of Padam on lipid profile, glycometabolism, immune system and oxidation-antioxidation system
, Atherosclerosis Suppls 4(2): 111-112 (2003)

2P-0347 Determinants of all-cause mortality in type 2 diabetic patients in Taiwan: A 6-year prospective follow-up
, Atherosclerosis Suppls 4(2): 114-115 (2003)

2P-0351 Mortality from cardiovascular diseases among individuals with type 1 diabetes in Japan, Finland, and Us
, Atherosclerosis Suppls 4(2): 115-116 (2003)

2P-0355 The effect of the cholesteryl ester transfer protein gene and apolipoprotein E gene on plasma lipoprotein in Vietnamese
, Atherosclerosis Suppls 4(2): 116-117 (2003)

2P-0359 Gender-specific efficacy of Hmg-CoA reductase inhibitors on the prevention of stroke: A meta-analysis of randomized, placebo-controlled, double-blind trials by gender
, Atherosclerosis Suppls 4(2): 117-118 (2003)

2P-0368 Concentration of glucose, homocysteine and Lp(a) as a risk factor of coronary artery disease
, Atherosclerosis Suppls 4(2): 119-120 (2003)

2P-0377 Changes of homocysteine levels after administration of folic acid
, Atherosclerosis Suppls 4(2): 121-122 (2003)

2P-0382 Homocysteine and premature coronary heart disease
, Atherosclerosis Suppls 4(2): 122-123 (2003)

2P-0400 Insulin-sensitizing and cardiovascular effects of Ace inhibitors in the Jcr:La-cp rat
, Atherosclerosis Suppls 4(2): 126-127 (2003)

2P-0409 Leptin-deficiency suppressed progression of atherosclerosis
, Atherosclerosis Suppls 4(2): 128-129 (2003)

2P-0418 Effects of pioglitazone treatment on postprandial lipid metabolism in type 2 diabetes
, Atherosclerosis Suppls 4(2): 130-131 (2003)

2P-0423 Ldl subfraction profile at baseline in a double-blind clinical trial with atorvastatin in patients with type 2 diabetes on hemodialysis (Die Deutsche Diabetes Dialysis Study)
, Atherosclerosis Suppls 4(2): 131-132 (2003)

2P-0435 The suppressive effect of acetoacetate on the expression of the Atp-binding cassette transporter A1 (Abca1) requires the E-box in the Abca1 promoter
, Atherosclerosis Suppls 4(2): 134-135 (2003)

2P-0439 Effect of Hmg CoA reductase inhibitor (statin) on Abca1 expression and Hdl-induced cholesterol efflux in macrophages
, Atherosclerosis Suppls 4(2): 135-136 (2003)

2P-0444 Localization of Abcg5 and Abcg8 proteins in human liver
, Atherosclerosis Suppls 4(2): 136-137 (2003)

2P-0451 The Abca1 transporter modulates late endocytic trafficking
, Atherosclerosis Suppls 4(2): 138-139 (2003)

2P-0455 Pma activation of macrophages stimulates fluid-phase endocytic uptake of native Ldl generating foam cells
, Atherosclerosis Suppls 4(2): 139-140 (2003)

2P-0460 Role of sterol regulatory element binding protein-1 (Srebp-1) in hepatic regeneration after partial hepatectomy
, Atherosclerosis Suppls 4(2): 140-141 (2003)

2P-0469 Angiotensin Ii type I receptor antagonist, irbesartan, prevents vascular cell adhesion molecule-1 expression in a rabbit model of early atherosclerosis
, Atherosclerosis Suppls 4(2): 142-143 (2003)

2P-0478 Analysis of Arg-Gly-Asp-contact sites in the v subunit of integrin v3 employing single amino acid mutations
, Atherosclerosis Suppls 4(2): 144-145 (2003)

2P-0482 Kr31378 ameliorates atherosclerosis by blocking recruitment and accumulation of monocytes in the hypercholesterolemic mice
, Atherosclerosis Suppls 4(2): 145-146 (2003)

2P-0486 Azelnidipine, a novel ca-antagonist, reduces endothelial inflammatory response induced by oxysterol
, Atherosclerosis Suppls 4(2): 146-147 (2003)

2P-0492 Endothelin-1 stimulates arterial Vcam-1 expression via Nadph oxidase-derived superoxide in low renin hypertension
, Atherosclerosis Suppls 4(2): 147-148 (2003)

2P-0496 Altered expression of matrix metalloproteinase and tissue inhibitor of metallproteinase genes in human carotid plaque: Evidence from quantitative analysis using real-time Rt-Pcr method
, Atherosclerosis Suppls 4(2): 148-149 (2003)

2P-0501 Characterisation of Par-4 receptor distribution in human atherosclerotic plaque tissue
, Atherosclerosis Suppls 4(2): 149-150 (2003)

2P-504 Development of an animal model for spontaneous myocardial infarction (Whhlmi rabbit)
, Atherosclerosis Suppls 4(2): 150-151 (2003)

2P-0509 Development of atherosclerotic calcification in ApoE-deficient mice
, Atherosclerosis Suppls 4(2): 151-152 (2003)

2P-0519 Longterm results of uni- versus bilateral carotid thrombendarterectomy: A single center experience
, Atherosclerosis Suppls 4(2): 153-154 (2003)

2P-0524 Cerebral infarction and ischemic heart disease in type 2 diabetes mellitus patients
, Atherosclerosis Suppls 4(2): 154-155 (2003)

2P-0534 Association of coronary atheorosclerosis with coronary flow velocity reserve evaluated by transthoracic Doppler echocardiography
, Atherosclerosis Suppls 4(2): 156-157 (2003)

2P-0543 Endothelial dysfunction: Non-invasive assessment and conventional determinants in a population
, Atherosclerosis Suppls 4(2): 158-159 (2003)

2P-0552 Pitavastatin induces plaque stabilization in Watanabe heritable hyperlipidemic rabbits
, Atherosclerosis Suppls 4(2): 160-161 (2003)

2P-0557 Atorvastatin's different doses lipid lowering, pleiotropic and plaque stability effects
, Atherosclerosis Suppls 4(2): 161-162 (2003)

2P-0562 Rosuvastatin reduces atherosclerosis development beyond and independently of its plasma cholesterol-lowering effect in Apoe3-Leiden transgenic mice. Evidence for anti-inflammatory effects of rosuvastatin
, Atherosclerosis Suppls 4(2): 162-163 (2003)

2P-0566 Effect of bezafibrate on high-density lipoprotein (Hdl) concentrations, Hdl particle size distribution, and Hdl-core weight ratio in primary hypertriglyceridemics with Cetp TaqIb B2 allele
, Atherosclerosis Suppls 4(2): 163-164 (2003)

2P-0580 Anti-atherosclerotic effect of the novel acyl-CoA: cholesterol acyltransferase inhibitor, K-10191, on high cholesterol-fed rabbits
, Atherosclerosis Suppls 4(2): 166-167 (2003)

2P-0584 Effect of nilvadipine on serum lipoproteins in patients with hypertension
, Atherosclerosis Suppls 4(2): 167-168 (2003)

2P-0597 Intravenous administration of a Rho-kinase inhibitor, fasudil, reduces pulmonary vascular resistance in patients with pulmonary hypertension
, Atherosclerosis Suppls 4(2): 170-171 (2003)

2P-0606 Long-term effects of Ldl-apheresis treatment and morphologic changes of coronary atherosclerotic lesions in two brothers of homozygous patients with familial hypercholesterolemia
, Atherosclerosis Suppls 4(2): 172-173 (2003)

2P-0609 Biovailability of dual therapy: A fixed-dose combination tablet of amlodipine and atorvastatin
, Atherosclerosis Suppls 4(2): 173-174 (2003)

2P-0613 Safety profile of rosuvastatin 1040 mg in an intergnational phase Ii/Iii clinical trial program
, Atherosclerosis Suppls 4(2): 174-175 (2003)

2P-0617 Pleiotropic effects after a 3-day treatment with the lipid lowering drugs in patients with coronary artery disease
, Atherosclerosis Suppls 4(2): 175-176 (2003)

3Sy05-6 Paraoxonase: Biochemistry and contribution to atherosclerosis
, Atherosclerosis Suppls 4(2): 177-178 (2003)

3Sy07-4 Signal transduction and gene regulation in vascular smooth muscle cells
, Atherosclerosis Suppls 4(2): 179-180 (2003)

3Fs06-6 Pdzk1 in hepatic Hdl metabolism
, Atherosclerosis Suppls 4(2): 181-182 (2003)

3Fs07-5 Narc-1: A potential new target for drug therapy of hypercholesterolemia
, Atherosclerosis Suppls 4(2): 182-183 (2003)

3Ws17-1 Stroke risk factors: Recent evidence and new aspects
, Atherosclerosis Suppls 4(2): 186-187 (2003)

3Ws17-6 Genetic risk factors for stroke: Insights into patho-physiology from candidate gene approaches
, Atherosclerosis Suppls 4(2): 187-188 (2003)

3Ws18-5 Role of elastolytic cathepsins in vascular remodeling
, Atherosclerosis Suppls 4(2): 188-189 (2003)

3Ws19-5 Macro and micro costing of atherosclerosis-related diseases in the Japanese health care system
, Atherosclerosis Suppls 4(2): 189-190 (2003)

3Ws20-6 Is liver the culprit of diabetic dyslipidemia?
, Atherosclerosis Suppls 4(2): 190-191 (2003)

3Ws22-2 Functional role and regulation of hepatic scavenger receptor class B type I (Sr-Bi)
, Atherosclerosis Suppls 4(2): 191-192 (2003)

3P-0628 Differential effects of hydrophilic and lipophilic statins on cell proliferation and apoptosis
, Atherosclerosis Suppls 4(2): 199-200 (2003)

3P-0642 Immunohistochemical expression of Vegf-C and D in the atherosclerotic intima of human coronary arteries
, Atherosclerosis Suppls 4(2): 202-203 (2003)

3P-0655 Stat-3 activation in smooth muscle cells (Smc) subjected to cyclic strain
, Atherosclerosis Suppls 4(2): 205-206 (2003)

3P-0664 Turbulent shear stress upregulates urokinase plasminogen activator gene expression in coronary artery endothelial cells
, Atherosclerosis Suppls 4(2): 207-208 (2003)

3P-0674 Fgf-2 signaling induces osteoblastic marker osteopontin gene expression and inhibits smooth muscle differentiation via Cbfa1 in rat aortic smooth muscle cells
, Atherosclerosis Suppls 4(2): 209-210 (2003)

3P-0679 Statins induce differentiated phenotype in human vascular smooth muscle cells through the inhibition of small Gtp-binding proteins
, Atherosclerosis Suppls 4(2): 210-211 (2003)

3P-0688 An Hmg-CoA reductase inhibitor inhibits the migration of smooth muscle cells through the Lr11-mediated urokinase receptor expression system in vitro
, Atherosclerosis Suppls 4(2): 212-213 (2003)

3P-0697 Induction of cyclooxygenase-2 by lysophosphatidylcholine in vascular smooth muscle cells: Involvement of p42/44 and p38Mapk pathway
, Atherosclerosis Suppls 4(2): 214-215 (2003)

3P-0715 Generation of monoclonal antibodies against nuclear hormone receptors using recombinant baculovirus displaying gp64-fusion proteins
, Atherosclerosis Suppls 4(2): 218-219 (2003)

3P-0719 Potential role of Kruppel-like transcription factor5 (Klf5) in adipocyte differentiation
, Atherosclerosis Suppls 4(2): 219-220 (2003)

3P-0728 Insulin enhances the clearance of modified low-density lipoprotein in vivo
, Atherosclerosis Suppls 4(2): 221-222 (2003)

3P-0733 The incidence of midband lipoproteins in Pag disk electrophoresis and metabolic disorders in patients with normolipidemia
, Atherosclerosis Suppls 4(2): 222-223 (2003)

3P-0738 Pitavastatin (Nk-104), an Hmg-CoA reductase inhibitor, is an efficient inducer of Ldl-receptor and reducer of cholesterol
, Atherosclerosis Suppls 4(2): 223-224 (2003)

3P-0747 Effect of pitavastatin on sterol and bile acid excretion in guinea pigs
, Atherosclerosis Suppls 4(2): 225-226 (2003)

3P-0751 Postprandial hyperlipidemia and increased remnant lipoproteins in human genetic Cd36 deficiency
, Atherosclerosis Suppls 4(2): 226-227 (2003)

3P-0756 Deposition of cholesterol from a lipid microemulsion in fragments of blood vessels excised from patients during coronary bypass surgery
, Atherosclerosis Suppls 4(2): 227-228 (2003)

3P-0761 Characterization of intermediate density lipoprotein particles that do and do not bind to chondroitin sulphate
, Atherosclerosis Suppls 4(2): 228-229 (2003)

3P-0765 The Vldl receptor plays a crucial role in postprandial lipoprotein metabolism
, Atherosclerosis Suppls 4(2): 229-230 (2003)

3P-0774 Serum Rlp-cholesterol levels in hypertriglyceridemia associated with hyperalphalipoproteinemia
, Atherosclerosis Suppls 4(2): 231-232 (2003)

3P-0779 Altered expression of endothelial cell-derived lipase in diseased vessel wall and its impact on Hdl metabolism
, Atherosclerosis Suppls 4(2): 232-233 (2003)

3P-0788 Severe chylomicronemia: Clinical epidemiology and recommendations for treatment
, Atherosclerosis Suppls 4(2): 234-235 (2003)

3P-0793 Comparative analysis between dextran sulfate adsorption and direct adsorption of lipoproteins (Dali) in their capability to reduce red blood cell adhesiveness/aggregation in the peripheral blood
, Atherosclerosis Suppls 4(2): 235-236 (2003)

3P-0798 A single base mutation (T to A) at position 190 in the apolipoprotein Cii promoter with apolipoprotein Cii deficiency
, Atherosclerosis Suppls 4(2): 236-237 (2003)

3P-0807 The effect of atorvastatin on Ldl particle size - A clue to atherosclerotic disease
, Atherosclerosis Suppls 4(2): 238-239 (2003)

3P-0812 The 1131T> C polymorphism in apolipoprotein A5 (Apoa5) is associated with elevated plasma triglycerides only in overweight patients
, Atherosclerosis Suppls 4(2): 239-240 (2003)

3P-0815 Comparison of the efficacy and safety of atorvastatin initiated at different starting doses
, Atherosclerosis Suppls 4(2): 240-241 (2003)

3P-0836 Biological characterization of Er129614-06, a novel, non-peptide protease-activated receptor-1 (Par-1) antagonist
, Atherosclerosis Suppls 4(2): 245-246 (2003)

3P-0845 Platelet glycoprotein Iib/Iiia P1A2/P1A2 homozygosity associated with risk of ischemic cardiovascular disease and myocardial infarction in young men. The Copenhagen City Heart Study
, Atherosclerosis Suppls 4(2): 247-248 (2003)

3P-0850 Lipopolysaccharide-induced thrombus formation in mice lacking vitamin D receptor
, Atherosclerosis Suppls 4(2): 248-249 (2003)

3P-0860 Cortisol secretion and atherosclerosis of retinal arteries in men
, Atherosclerosis Suppls 4(2): 250-251 (2003)

3P-0865 Minocycline for the treatment of Takayasu arteritis
, Atherosclerosis Suppls 4(2): 251-252 (2003)

3P-0869 Initial and long-term clinical result of endoluminal stenting for obstructive lesions of the subclavian artery: Multicenter registry in Japan
, Atherosclerosis Suppls 4(2): 252-253 (2003)

3P-0874 The mobilization of endothelial progenitor cells in accordance with arterial sclerosis
, Atherosclerosis Suppls 4(2): 253-254 (2003)

3P-0878 A mouse model to study the role of ApoE in atherosclerosis regression and plaque vulnerability in peripheral arterial disease
, Atherosclerosis Suppls 4(2): 254-255 (2003)

3P-0883 B- and M-mode ultrasound studies of arterial wall thickness and arterial wall stiffness in patients with Marfan syndrome and unaffected controls
, Atherosclerosis Suppls 4(2): 255-256 (2003)

3P-0887 Ldl receptor gene therapy protects against atherosclerosis in a mouse model of familial hypercholesterolemia
, Atherosclerosis Suppls 4(2): 256-257 (2003)

3P-0892 Changes in hs-Crp and Tc/Hdl with transdermal vs. oral Hrt and atorvastatin aiming at primary prevention of cardiovascular diseases
, Atherosclerosis Suppls 4(2): 257-258 (2003)

3P-0897 The effect of selective estrogen receptor modulators (Serms) on lipid metabolism
, Atherosclerosis Suppls 4(2): 258-259 (2003)

3P-0901 Single-nucleotide polymorphism (Snp) haplotypes in the adiponectin (Apm1) gene with relation to serum adiponectin, body fat distribution, and the severity of atherosclerosis in elderly women
, Atherosclerosis Suppls 4(2): 259-260 (2003)

3P-0905 Investigation of the new criteria of normal serum lipid levels in Japanese children: The nationwide study
, Atherosclerosis Suppls 4(2): 260-261 (2003)

3P-0913 Statin therapy in hypercholesterolemic children. Long-term efficacy and safety
, Atherosclerosis Suppls 4(2): 262-263 (2003)

3P-0917 Paraoxonase activity modulates endothelial function in patients with peripheral arterial disease
, Atherosclerosis Suppls 4(2): 263-264 (2003)

4Sy08-5 Vascular progenitors in adult tissues
, Atherosclerosis Suppls 4(2): 265-266 (2003)

4Sy09-4 Ca2+ regulation of signal transduction in the endothelium
, Atherosclerosis Suppls 4(2): 266-267 (2003)

4Ws25-4 Aging suppressor gene klotho and vascular endothelium
, Atherosclerosis Suppls 4(2): 269-270 (2003)

4Ws27-1 Population differences in serum total cholesterol level and coronary heart disease
, Atherosclerosis Suppls 4(2): 271-272 (2003)

4Ws27-6 Geographical distribution of risk factors for atherosclerosis
, Atherosclerosis Suppls 4(2): 272-273 (2003)

4P-0923 Serum vitamins E, A and lipid peroxidation levels in Kurichias, an Indian tribal population
, Atherosclerosis Suppls 4(2): 276-277 (2003)

4P-0933 Effect of lemon flavonoids on resistance of Ldl to oxidation
, Atherosclerosis Suppls 4(2): 278-279 (2003)

4P-0937 Effects of dietary fatty acids on lipoprotein metabolism and changes in hepatic protein levels in apolipoprotein E3-Leiden transgenic mice
, Atherosclerosis Suppls 4(2): 279-280 (2003)

4P-0946 Cyanidin-3-glucoside, a typical anthocyanin pigment, induces expression of endothelial nitric oxide synthase through Src-Erk1/2 signaling pathway
, Atherosclerosis Suppls 4(2): 281-282 (2003)

4P-0950 Baseline diet glycemic load and glycemic index are determinants of Hdl cholesterol levels in patients with coronary heart disease: results from the Lipid study
, Atherosclerosis Suppls 4(2): 282-283 (2003)

4P-0963 Structure and function of novel oxidized-Ldl receptors in endothelial cell
, Atherosclerosis Suppls 4(2): 285-286 (2003)

4P-0967 Acidic pH protects against oxidised Ldl-induced apoptosis: possible role of Nf-kB
, Atherosclerosis Suppls 4(2): 286-287 (2003)

4P-0972 Lipoprotein(a) inhibits Paf-induced activation of human platelets in a manner independent of the endogenous Paf-acetylhydrolase activity
, Atherosclerosis Suppls 4(2): 287-288 (2003)

4P-0981 Enhanced oxidative stress and endothelial dysfunction in patients with familial hypercholesterolaemia
, Atherosclerosis Suppls 4(2): 289-290 (2003)

4P-0990 Mulberry leaf extracts inhibit expression of lectin-like oxidized Ldl receptor-1 (Lox-1) in vascular endothelial cells
, Atherosclerosis Suppls 4(2): 291-292 (2003)

4P-0993 Suppression of atherosclerosis by Mulberry leaf
, Atherosclerosis Suppls 4(2): 292-293 (2003)

4P-1002 The effect of cigarette smoke, nicotine and cotinine on red blood cell hemolysis and -Sh capacity
, Atherosclerosis Suppls 4(2): 294-295 (2003)

4P-1007 Anti-atherogenic activity of Hdl particle subspecies: Evidence for impaired antioxidative function in normocholesterolemic low Hdl states
, Atherosclerosis Suppls 4(2): 295-296 (2003)

4P-1012 Quick and sensitive monitoring of oxidatively modified low density lipoprotein (Ldl) subfractions by capillary isotachophoresis (cItp)
, Atherosclerosis Suppls 4(2): 296-297 (2003)

4P-1016 Na2003: as a novel Vldl-secretion inhibitor
, Atherosclerosis Suppls 4(2): 297-298 (2003)

4P-1020 High cholesterol diet induced alterations in the enzymes of lipoprotein metabolism and modulation by treatment with piperine
, Atherosclerosis Suppls 4(2): 298-299 (2003)

4P-1025 The recovery of dysfunctional Lpl (Asp204-Glu) activity by modification of substrate
, Atherosclerosis Suppls 4(2): 299-300 (2003)

4P-1034 A novel nonsense mutation of cholesterol ester transfer protein gene and the clinical characterization of Japanese primary hyperalphalipoproteinemias
, Atherosclerosis Suppls 4(2): 301-302 (2003)

4P-1047 A new Hmg-CoA reductase inhibitor, pitavastatin retards remarkably the progression of high cholesterol induced atherosclerosis in rabbits Relevance of nitric oxide and superoxide anion
, Atherosclerosis Suppls 4(2): 304-305 (2003)

4P-1056 Interrelationship between circulating C-reactive protein and oxidative stress in men
, Atherosclerosis Suppls 4(2): 306-307 (2003)

4P-1060 Basal production of nitric oxide is increased in the microcirculation in type 2 diabetes despite endothelial dysfunction: association with oxidative stress and blood pressure
, Atherosclerosis Suppls 4(2): 307-308 (2003)

4P-1065 Secreted heat shock protein 90-alpha is a novel mediator of oxidative stress via pro-inflammatory effects on vascular cells
, Atherosclerosis Suppls 4(2): 308-309 (2003)

4P-1070 Medial smooth muscle cells are replaced by host derived cells after carotid artery transplantation in transgenic mice expressing green fluorescent protein
, Atherosclerosis Suppls 4(2): 309-310 (2003)

4P-1080 Decreased elasticity of large arteries and increased vascular resistance in patients suffering from systemic lupus erythematosus
, Atherosclerosis Suppls 4(2): 311-312 (2003)

4P-1089 Activation of mononuclear cells and their adhesiveness to vascular endothelial cells under chronic oxidative stress in clinical and experimental atherosclerosis
, Atherosclerosis Suppls 4(2): 313-314 (2003)

4P-1098 Novel immunological risk factors for atherosclerosis
, Atherosclerosis Suppls 4(2): 315-316 (2003)

4P-1103 Expression of macrophage-derived chemokine in U937 cells
, Atherosclerosis Suppls 4(2): 316-317 (2003)

4P-1107 Increase in plasma propionate after chronic supplementation of diet with lactobacillus plantarum 299 v effect on inflammatory markers and adhesion molecules
, Atherosclerosis Suppls 4(2): 317-318 (2003)

4P-1111 A small-molecule human Mcp-1 receptor (Ccr2B) antagonist with a highly species specificity
, Atherosclerosis Suppls 4(2): 318-319 (2003)

4P-1120 Influences of matrix metalloproteinase-3 gene variation on extent of coronary atherosclerosis and risk of myocardial infarctiona
, Atherosclerosis Suppls 4(2): 320-321 (2003)

4P-1124 Co-operative polymorphisms of matrix metalloproteinase 3 and 9 and area of coronary artery lesions related to risk of acute coronary events
, Atherosclerosis Suppls 4(2): 321-322 (2003)

4P-1128 Modular cis-acting elements required for the 2(Iv) collagen promoter in tissue-specific transcription
, Atherosclerosis Suppls 4(2): 322-323 (2003)

4P-1142 Stenting of coronary bifurcation lesions: Y-stening, T-stenting, single stenting, immediate and long-term results: Multicenter registry in Japan
, Atherosclerosis Suppls 4(2): 325-326 (2003)

4P-1146 In the state of increased oxidative stress, edarovone, a free radical scavenger, favorably blunted vascular injury response
, Atherosclerosis Suppls 4(2): 326-327 (2003)

4P-1155 Measurement of soluble FcRiiiaM derived from macrophages in plasma as a novel marker for atherosclerosis
, Atherosclerosis Suppls 4(2): 328-329 (2003)

4P-1164 Effect of pravastatin on the aortic gene expression of ApoE-deficient mice fed with a hypercholesterolemic diet
, Atherosclerosis Suppls 4(2): 330-331 (2003)

4P-1173 Uric acid induced the expression of C-reactive protein (Crp) in vascular smooth muscle cells (Vsmc) via Map kinase-dependent and angiotensin Ii-mediated pathway
, Atherosclerosis Suppls 4(2): 332-333 (2003)

4P-1182 Simvastatin affects hemostasis, endothelial function and Cd40L in capd patients
, Atherosclerosis Suppls 4(2): 334-335 (2003)

4P-1186 Effects of immunosuppressive therapy on blood lipid profile after renal transplantation
, Atherosclerosis Suppls 4(2): 335-336 (2003)

4P-1195 Prescription frequency of herbal medicines in Chinese patients with type 2 diabetes mellitus
, Atherosclerosis Suppls 4(2): 337-338 (2003)

4P-1200 Amirkabiria odoratissima, an anti-inflammatory drug, prevents development of fatty streak
, Atherosclerosis Suppls 4(2): 338-339 (2003)

4P-1204 Multiorgan atherosclerotic disease in a young patient affected by hyperhomocysteinemia with multiple heterozygous mutations
, Atherosclerosis Suppls 4(2): 339-340 (2003)

W01.9 Infectious agents, inflammation and acute coronary syndromes: Coxackie B virus, acute phase proteins and their potentional role in atherosclerosis
, Atherosclerosis Suppls 5(1): 2-3 (2004)

W01.13 Comparative study of the pharmacological effects of troglitazone, mevinolin and Ly379196 on Ldl receptor, Vldl receptor and macrophage scavenger receptor, Cd36, in macrophage-derived-monocytes
, Atherosclerosis Suppls 5(1): 3-4 (2004)

W01.17 Matrix metalloproteinase 2 and 9 evaluation in patients with or without diabetes during acute coronary syndrome and after the acute event
, Atherosclerosis Suppls 5(1): 4-5 (2004)

W01.22 Insulin levels and Hs-Crp in a group of mediterranean women: Findings from progetto atena
, Atherosclerosis Suppls 5(1): 5-6 (2004)

W01.27 The mechanism of endothelium independent vasorelaxation induced by wine polyphenol resveratrol
, Atherosclerosis Suppls 5(1): 6-7 (2004)

W01.32 Carvedilol inhibits lipid peroxidation in patients with stable angina
, Atherosclerosis Suppls 5(1): 7-8 (2004)

W01.45 Interaction between autologous human plaque-derived vascular smooth muscle cells, type 1 Nkt and Cd4+ T cells: Implication for atherosclerosis disease progression
, Atherosclerosis Suppls 5(1): 10-11 (2004)

W01.54 Acrylamide from processed foodNew potential risk factor for plaque rupture
, Atherosclerosis Suppls 5(1): 12-13 (2004)

W01.59 Cytomegalovirus inducible gene 5 is induced in human and rodent vascular inflammation and atherosclerosis
, Atherosclerosis Suppls 5(1): 13-14 (2004)

W01.68 Hemoglobin scavenging human macrophages elicit haptoglobin phenotype dependent anti-inflammatory responses with potential atheroprotective implications
, Atherosclerosis Suppls 5(1): 15-16 (2004)

W01.72 Oxidized Ldl induces calpain-dependent cell death and ubiquitination of caspase-3 in Hmec-1 endothelial cells
, Atherosclerosis Suppls 5(1): 16-17 (2004)

W01.76 Biophenols reduce oxLdl uptake by macrophage scavenger receptors
, Atherosclerosis Suppls 5(1): 17-18 (2004)

W01.85 Unsaturated fatty acid-induced inflammatory environments in human endothelial cells
, Atherosclerosis Suppls 5(1): 19-20 (2004)

W01.97 Correlation between positive family history of cardiovascular disease and inflammatory factors for children and adolescents
, Atherosclerosis Suppls 5(1): 22-23 (2004)

W01.107 Estrogen receptor expression is altered in the aorta during diabetes and inflammation
, Atherosclerosis Suppls 5(1): 24-25 (2004)

W02.117 The absence of transthyretin influences mouse fat and glucose metabolism
, Atherosclerosis Suppls 5(1): 26-27 (2004)

W01.121 Sex-relaetd differential effect of in aged rats
, Atherosclerosis Suppls 5(1): 27-28 (2004)

W01.125 Lipoprotein lipase variant N291S is associated with hypertriglyceridemia in familial combined hyperlipidemia
, Atherosclerosis Suppls 5(1): 28-29 (2004)

W01.129 Signal transduction pathways and transcriptional control mechanisms involved in the cytokine-mediated regulation of key genes in macrophages implicated in foam cell formation and atherosclerosis
, Atherosclerosis Suppls 5(1): 29-30 (2004)

W04.138 Transcriptional regulation of macrophage lipoprotein lipase gene expression by transforming growth factor-beta
, Atherosclerosis Suppls 5(1): 31-32 (2004)

W04.141 Regulation of the monocyte cyclooxigenase-2 mRna by inflammatory mediators and lipids
, Atherosclerosis Suppls 5(1): 32-33 (2004)

W04.146 Correlation between Il-1, Il-6 and Hdl serum levels
, Atherosclerosis Suppls 5(1): 33-34 (2004)

W04.150 Leptin levels in subjects with familial combined hyperlipidemia
, Atherosclerosis Suppls 5(1): 34-35 (2004)

W05.154 Decrease in pH enhances aggregation of modified Ldl particles and the binding of Ldl to human arterial proteoglycans
, Atherosclerosis Suppls 5(1): 35-36 (2004)

W05.158 Binding of lipoprotein(a) to laminin: In vivo and in vitro evidences
, Atherosclerosis Suppls 5(1): 36-37 (2004)

W06.167 Cetp activity is not influenced by Efavirenz
, Atherosclerosis Suppls 5(1): 38-39 (2004)

W07.179 Vaccination against interleukin 12 attenuates atherosclerosis in Ldl receptor deficient mice
, Atherosclerosis Suppls 5(1): 41-42 (2004)

W07.184 Serum activity of proinflammatory cytokines in patients with unstable angina or non persistent St elevation myocardial infarction. Effects of short term atorvastatin administration
, Atherosclerosis Suppls 5(1): 42-43 (2004)

W08.192 Genes regulated by phytosterol-treatment in a murine model of dyslipemia and atherosclerosis
, Atherosclerosis Suppls 5(1): 44-45 (2004)

W08.196 Role of adipophilin on lipid accumulation in human macrophages
, Atherosclerosis Suppls 5(1): 45-46 (2004)

W09.200 Insulin resistance is associated with increased Vldl triglyceride and Vldl apoC-Iii production
, Atherosclerosis Suppls 5(1): 46-47 (2004)

W09.204 Fenofibrate increases Hdl Lpai-Aii production in men with the metabolic syndrome
, Atherosclerosis Suppls 5(1): 47-48 (2004)

W09.217 Association between plasma adiponectin levels and adipose tissue compartments in men
, Atherosclerosis Suppls 5(1): 50-51 (2004)

W09.221 Metabolic syndrome X in hypertensive patients. From guidelines to clinical practice
, Atherosclerosis Suppls 5(1): 51-52 (2004)

W09.225 Post heart protection study; which lipid guidelines to adopt for diabetics?
, Atherosclerosis Suppls 5(1): 52-53 (2004)

W09.234 Metabolic syndrome in Finnish young adults: Prevalence and association to carotid artery intima-media thickness. The cardiovascular risk in young Finns study
, Atherosclerosis Suppls 5(1): 54-55 (2004)

W09.243 Metabolic syndrome in elderly patients suffering a first-ever acute ischemic stroke
, Atherosclerosis Suppls 5(1): 56-57 (2004)

W09.248 Effects of the metabolic syndrome on arterial stiffness in hypertensive subjects
, Atherosclerosis Suppls 5(1): 57-58 (2004)

W10.269 Very low density lipoprotein potentiates tumor necrosis factor expression in macrophages
, Atherosclerosis Suppls 5(1): 62-63 (2004)

W11.274 Regulation of the Abca1 transporter activity by protein kinase Ck2
, Atherosclerosis Suppls 5(1): 63-64 (2004)

W12.296 A novel and simple method for quantification of small dense Ldl and its clinical significance
, Atherosclerosis Suppls 5(1): 68-69 (2004)

W12.300 Saturated fat administration in healthy volunteers is associated with postprandial endothelial dysfunction which is totally reversed by the concomitant intake of red wine
, Atherosclerosis Suppls 5(1): 69-70 (2004)

W12.309 Novel Elisa for Apo B-48 revealed chylomicron remnants (Cr) are accumulated in the serum of diabetic patients despite normolipidemia
, Atherosclerosis Suppls 5(1): 71-72 (2004)

W13.318 Lipemic and glycemic responses to ciprofibrate treatment in genetic dyslipidemic mice
, Atherosclerosis Suppls 5(1): 73-74 (2004)

W13.322 Effect of different Ldls on endothelial cell barrier function
, Atherosclerosis Suppls 5(1): 74-75 (2004)

W13.327 Overexpression of mitochondrial glycerol-3-phosphate acyltransferase in rat hepatocytes leads to decreased fatty acid oxidation and increased glycerolipid biosynthesis
, Atherosclerosis Suppls 5(1): 75-76 (2004)

W13.331 Different types of enzymatic modification cause aggregation of low density lipoprotein and intracellular cholesterol accumulation
, Atherosclerosis Suppls 5(1): 76-77 (2004)

W13.340 A novel non-truncating Apob gene mutation, L343V, causes familial hypobetalipoproteinaemia
, Atherosclerosis Suppls 5(1): 78-79 (2004)

W14.344 A novel missense mutation in Pcsk9 co-segregates with hypercholesterolaemia in patients from two families of english descent
, Atherosclerosis Suppls 5(1): 79-80 (2004)

W14.353 The genetic background of obesity treatment efficacy the different results in beta 2-adrenergic receptor Gln27Glu carriers
, Atherosclerosis Suppls 5(1): 81-82 (2004)

W14.357 Methylenetetrahydrofolate reductase C677T, moderate hyperhomocysteinemia, and risk of ischemic cardiovascular disease and venous thromboembolism
, Atherosclerosis Suppls 5(1): 82-83 (2004)

W14.361 Polymorphism in the Abcg5 and Abcg8 genes and cholesterol and glucose metabolism in mild hypercholesterolemia
, Atherosclerosis Suppls 5(1): 83-84 (2004)

W14.366 Genetics of cholesteryl ester transfer protein in a Brazilian population
, Atherosclerosis Suppls 5(1): 84-85 (2004)

W14.383 Validation of single strand conformation polymorphism (Sscp) analysis in the detection of mutations in genes such as that coding for the Ldl receptor
, Atherosclerosis Suppls 5(1): 88-89 (2004)

W14.392 Familial hypobetalipoproteinemia with no truncated forms of apolipoprotein B detectable in plasma
, Atherosclerosis Suppls 5(1): 90-91 (2004)

W14.396 The effects of paraoxonase on cholesterol lowering by simvastatin and atorvastatin
, Atherosclerosis Suppls 5(1): 91-92 (2004)

W15.400 Differences in the seasonal variation of plasma fibrinogen between dipper and nondipper hypertensive patients
, Atherosclerosis Suppls 5(1): 92-93 (2004)

W15.409 Is hyperhomocystinemia a distinctive feature in young patients with myocardial infarction?
, Atherosclerosis Suppls 5(1): 94-95 (2004)

W15.418 Extralipid effects of atorvastatin in patients with hypercholesterolemia
, Atherosclerosis Suppls 5(1): 96-97 (2004)

W15.422 Ca2+-activated K+ channels contribute to lysophosphatidylcholine induced endothelial dysfunction
, Atherosclerosis Suppls 5(1): 97-98 (2004)

W15.427 Lipoprotein composition related to metabolic syndrome as parameters influencing platelet adhesion
, Atherosclerosis Suppls 5(1): 98-99 (2004)

W15.431 Ffr-rFviia by blocking blood-borne tissue factor inhibits thrombosis triggered by ruptured vessel wall
, Atherosclerosis Suppls 5(1): 99-100 (2004)

M.444 Gallic acid is a potent antagonist of P-selectin: Implications for the French paradox
, Atherosclerosis Suppls 5(1): 102-103 (2004)

M.460 Apo E genotyping: Accurate, simple, high throughput method using Abi Prism snapshot multiplex system
, Atherosclerosis Suppls 5(1): 106-107 (2004)

M.464 Effect of rosuvastatin and atorvastatin on Ldl-C and Crp levels in patients with type-2 diabetes: Results of the andromeda study
, Atherosclerosis Suppls 5(1): 107-108 (2004)

M.473 Use of lipid lowering drugs according to cholesterol value and absolute cardiovascular risk
, Atherosclerosis Suppls 5(1): 109-110 (2004)

M.477 Ambulatory blood pressure pattern in patients with resistant hypertension as a function of the circadian time of antihypertensive therapy
, Atherosclerosis Suppls 5(1): 110-111 (2004)

M.481 Oxidized Ldl in middle-aged type 2 diabetes patients without coronary heart disease
, Atherosclerosis Suppls 5(1): 111-112 (2004)

M.486 Cysteine protease-cathepsins and vascular remodeling after balloon-injury
, Atherosclerosis Suppls 5(1): 112-113 (2004)

M.497 The economic assessment of lipid lowering therapy with ezetimibe vs atorvastatin titration in Spain
, Atherosclerosis Suppls 5(1): 114-115 (2004)

M.501 M-mode ultrasound imaging of arterial wall movement and arterial wall thickness of distal carotid arteries in atherosclerosis studies in healthy adults
, Atherosclerosis Suppls 5(1): 115-116 (2004)

M.510 Fluvastatin Er formulation reduces cholesterol biosynthesis independent of daytime of administration
, Atherosclerosis Suppls 5(1): 117-118 (2004)

M.514 High throughput genotyping using the Abi prism 7900Ht sequence detection system
, Atherosclerosis Suppls 5(1): 118-119 (2004)

M.530 Elevated ambulatory pulse pressure in patients with type 2 diabetes mellitus
, Atherosclerosis Suppls 5(1): 122-123 (2004)

M.534 Achievement of treatment goals
, Atherosclerosis Suppls 5(1): 123-124 (2004)

M.542 Ldl-C/Hdl-C ratio in patients with coronary artery disease and low Hdl-C: The radar study
, Atherosclerosis Suppls 5(1): 125-126 (2004)

M.551 Alpha-1 antitrypsine: Distinct role in inflammatory process and its prognostic significance patients with unstable angina
, Atherosclerosis Suppls 5(1): 127-128 (2004)

M.555 Assessing pulse wave velocity and biophysical properties of the aorta in patients with end-stage renal disease
, Atherosclerosis Suppls 5(1): 128-129 (2004)

M.559 Correlation of autoantibody titers against various forms of oxidized Ldl with carotid intima media thickness (Imt) in hyperlipidemic patients
, Atherosclerosis Suppls 5(1): 129-130 (2004)

M.563 Carotid vs femoral atherosclerosis: Which can better predict coronary artery disease?
, Atherosclerosis Suppls 5(1): 130-131 (2004)

M.568 The evaluation of short and long term administration of drugs improving life expectancy in patients with myocardial infarction
, Atherosclerosis Suppls 5(1): 131-132 (2004)

M.572 Invasive measurements of pulse wave velocity correlate with the degree of echocardiographic aortic valve calcification and its severity in aged patients with degenerative aortic valve stenosis
, Atherosclerosis Suppls 5(1): 132-133 (2004)

M.576 A complete genetic diagnostic method for familial hypercholesterolaemia
, Atherosclerosis Suppls 5(1): 133-134 (2004)

M.580 Antioxidant vitamins (A, E and C) in the risk profile of cardiovascular disease in dyslipidemic patients
, Atherosclerosis Suppls 5(1): 134-135 (2004)

M.589 Pulse wave velocity in young adults is independent of plasma homocysteine
, Atherosclerosis Suppls 5(1): 136-137 (2004)

M.593 Anti-atherosclerotic effects of garlic powder time-released tablets
, Atherosclerosis Suppls 5(1): 137-138 (2004)

M.602 A walnut diet improves endothelial function in hypercholesterolemic subjects: A randomized crossover trial
, Atherosclerosis Suppls 5(1): 139-140 (2004)

M.606 Efficacy and safety of ezetimibe/simvastatin combination tablet compared with simvastatin alone in patients with primary hypercholesterolemia
, Atherosclerosis Suppls 5(1): 140-141 (2004)

M.610 Long-term rosuvastatin treatment protects against nitrate-induced oxidative stress
, Atherosclerosis Suppls 5(1): 141-142 (2004)

M.619 Assessment of metabolism of native and oxidized low density lipoprotein in vivo: Insights from animal positron emission tomography (micropet) studies
, Atherosclerosis Suppls 5(1): 143-144 (2004)

M.624 Novel mouse model for rapid screening of anti-restenotic drugs using a drug eluting perivascular device
, Atherosclerosis Suppls 5(1): 144-145 (2004)

M.628 Patients who continue to smoke after a myocardial infarction constitute a subgroup that requires a special attention
, Atherosclerosis Suppls 5(1): 145-146 (2004)

M.633 Comparison of the effects of cholesterol and desmosterol on the cell cycle of a Dhcr24-deficient cell line
, Atherosclerosis Suppls 5(1): 146-147 (2004)

M.650 Non-stenotic echolucent plaques in the carotid arteries in clinically healthy, 58-year old men predict cardiovascular events
, Atherosclerosis Suppls 5(1): 150-151 (2004)

M.664 Ldl subclasses distribution in different ethnic groups in Macedona
, Atherosclerosis Suppls 5(1): 153-154 (2004)

M.669 Effect of fenofibrate on Ldl subfractions in patients with combined dyslipidemia
, Atherosclerosis Suppls 5(1): 154-155 (2004)

M.673 Dipper behaviour and blood pressure with different antihypertensive medications
, Atherosclerosis Suppls 5(1): 155-156 (2004)

M.678 Relationship of calculated Ldl-C with Apob levels in subjects with normal and elevated levels of triglycerides
, Atherosclerosis Suppls 5(1): 156-157 (2004)

M.686 Carotid ultra sound examination as a diagnostic and motivational tool in vascular risk factor clinics
, Atherosclerosis Suppls 5(1): 158-159 (2004)

M.690 Unbalanced lipid peroxidation as risk factor for coronary artery disease in type 2 diabetics
, Atherosclerosis Suppls 5(1): 159-160 (2004)

W01-O-002 Endothelial monocyte derived activating polypeptide-Ii (Emap-H): A new inducer of matrix metalloproteinase-1 (Mmp-1) in cells of the atherosclerotic plaques
, Atherosclerosis Suppls 6(1): 1-2 (2005)

W01-P-007 Lercanidipine reduces free cholesterol-induced cytotoxicity
, Atherosclerosis Suppls 6(1): 3-4 (2005)

W01-P-011 Serum Lps and antibodies to periodontal bacteria associate with recurrent cardiovascular events
, Atherosclerosis Suppls 6(1): 4-5 (2005)

W01-P-015 Gemfibrozil in patients with acute coronary syndrome does not exhibit favourable rapid pleiotropic effects
, Atherosclerosis Suppls 6(1): 5-6 (2005)

W02-Is-002 Genetics, diet and healthy aging: The importance of cardiovascular disease prevention
, Atherosclerosis Suppls 6(1): 6-7 (2005)

W02-P-001 Apoaiv variant Gln360His influences thechange in plasma cholesterol concentrations in response to population dietary change in an 8 year follow-up
, Atherosclerosis Suppls 6(1): 7-8 (2005)

W02-P-009 The apolipoprotein E gene promoter 219G/T polymorphism determines insulin sensitivity in response to dietary fat in healthy young people
, Atherosclerosis Suppls 6(1): 9-10 (2005)

W02-P-013 Tnf- -308G> a polymorphism is not a risk factor for coronary disease (Cid) in a Greek-Cypriot cohort
, Atherosclerosis Suppls 6(1): 10-11 (2005)

W03-Is-002 Molecular abnormalities in endothelial cell-plasma protein interactions
, Atherosclerosis Suppls 6(1): 11-12 (2005)

W03-P-001 Increased circulating endothelial cells in acute congestive heart failure: Comparison
, Atherosclerosis Suppls 6(1): 12-13 (2005)

W03-P-005 Evaluation of nitric oxide, platelet fibronectin and platelet aggregation levels in coronary heart disease
, Atherosclerosis Suppls 6(1): 13-14 (2005)

W03-P-012 Lipoproteins affect endothelial function and thrombosic mechanisms in young individuals
, Atherosclerosis Suppls 6(1): 15-16 (2005)

W04-O-001 Promotion of angiogenesis and blood supply restoration in ischemic skeletal muscle of rat after low-voltage electrical stimulation
, Atherosclerosis Suppls 6(1): 16-17 (2005)

W04-P-002 Association of Mmp-3 5A/6A and Nos3 G894T polymorphisms with hypertension and serum Hdl cholesterol level
, Atherosclerosis Suppls 6(1): 17-18 (2005)

W04-P-006 Hmg-Coa reductase inhibitors, via Rhoproteins, decrease angiotensin H-induced connective tissue growth factor in vascular smooth muscle cells
, Atherosclerosis Suppls 6(1): 18-19 (2005)

W05-O-002 Gene-statin interactions: The influenceof paraoxonase-1 promoter polymorphism C-107T on up-regulation of gene expression by simvastatin
, Atherosclerosis Suppls 6(1): 19-20 (2005)

W06-P-001 Apolipoprotein Av expression in Prague hypertriglyceridemic rats
, Atherosclerosis Suppls 6(1): 22-23 (2005)

W06-P-008 Apoav variant Ala315> Val has no effect on plasma triacylglycerols in a Czech male cohort
, Atherosclerosis Suppls 6(1): 24-25 (2005)

W07-P-002 Serum Hdl-C levels of turkish patients with glucose abnormalities
, Atherosclerosis Suppls 6(1): 26-27 (2005)

W07-P-006 Familial lecithin-cholesterol acyltransferase deficiency: Characteristics of the carriers of a new Lcat gene mutation from a polish family
, Atherosclerosis Suppls 6(1): 27-28 (2005)

W07-P-010 Characteristics of the Hdl-C particle size in low Hdl-C family members
, Atherosclerosis Suppls 6(1): 28-29 (2005)

W08-O-003 Adiponectin and its association with metabolic syndrome, inflammatory markers and dyslipidemic phenotypes
, Atherosclerosis Suppls 6(1): 29-30 (2005)

W08-P-004 Lipoprotein (A) and apolipoprotein B Relationship with other risk factors for atherosclerosis in patients with metabolic syndrome
, Atherosclerosis Suppls 6(1): 30-31 (2005)

W08-P-012 Possible involvement of Amp-activated protein kinase in adipocytes in regulation of adiposity
, Atherosclerosis Suppls 6(1): 32-33 (2005)

W08-P-028 B-type natriuretic peptide and endothelin in high cardiovascular risk patients without target-organ damage
, Atherosclerosis Suppls 6(1): 36-37 (2005)

W09-Is-001 What can genetics offer in understanding the pathogenesis of coronary heart disease?
, Atherosclerosis Suppls 6(1): 38-39 (2005)

W09-O-003 Tumor necrosis factor-alpha plays a
, Atherosclerosis Suppls 6(1): 39-40 (2005)

W09-P-004 Effect of pravastatin on sympathetic innervation in hyperlipidemic rabbits
, Atherosclerosis Suppls 6(1): 40-41 (2005)

W09-P-009 Oral administration of eicosapentanoic acid reduces and stabilizes atherosclerotic lesions in apoE-deficient mice
, Atherosclerosis Suppls 6(1): 41-42 (2005)

W09-P-013 Atorvastatin and its effects on the endothelial expression of Vcam-1 and Icam-1 in Apoe Ko mouse model of atherosclerosis
, Atherosclerosis Suppls 6(1): 42-43 (2005)

W09-P-017 High glucose levels abolish antiatherosclerotic benefits of ace inhibition in alloxan-induced diabetes in rabbits
, Atherosclerosis Suppls 6(1): 43-44 (2005)

W09-P-022 The role of sterol 27-iiydroxylase inatherosclerosis: Bone marrow transplantations in genetically modified mice
, Atherosclerosis Suppls 6(1): 44-45 (2005)

W09-P-026 Exercise training increases skeletal muscle Ldl uptake
, Atherosclerosis Suppls 6(1): 45-46 (2005)

W10-O-001 Endothelial lipase deficiency increases plasma cholesterol but reduces susceptibility to atherosclerosis in apolipoprotein E-deficient mice
, Atherosclerosis Suppls 6(1): 46-47 (2005)

W10-P-002 Ageing and cardiovascular diseases,implication of Hdl and paraoxonase in reverse cholesterol transport
, Atherosclerosis Suppls 6(1): 47-48 (2005)

W10-P-006 Hts assay development for cardiovascular-relevant lipases
, Atherosclerosis Suppls 6(1): 48-49 (2005)

W10-P-010 Different metabolic behaviors in the fasting and the post-alimentary periods clarify the association of lipemia with atherosclerosis markers
, Atherosclerosis Suppls 6(1): 49-50 (2005)

W10-P-014 Knockdown of hepatic Abca1 decreases plasma Hdl cholesterol levels and influences postprandial lipemia in mice
, Atherosclerosis Suppls 6(1): 50-51 (2005)

W10-P-018 Design of a study comparing torcetrapib/atorvastatin with atorvastatin alone on atherosclerosis in patients with familial hypercholesterolemia
, Atherosclerosis Suppls 6(1): 51-52 (2005)

W10-P-022 Chymase treatment of Hdl3 increased their ability to transfer cholesterol esters and phospholipids mediated by plasma lipid transfer proteins
, Atherosclerosis Suppls 6(1): 52-53 (2005)

W10-P-025 Delayed postprandial clearance of chylomicrons and decreased lipoprotein lipase (Lpl) activity in persons with echolucent carotid plaques
, Atherosclerosis Suppls 6(1): 53-54 (2005)

W11-O-003 Ace I/D genetic polymorphism affects the expression of interleukin-6, P-selectin and oxidative stress status during the acute phase of myocardial infarction
, Atherosclerosis Suppls 6(1): 56-57 (2005)

W11-P-005 Relationship among urinary albumin excretion rate, lipoprotein lipase Pvuii polymorphism and plasma fibrinogen in type 2 diabetic patients
, Atherosclerosis Suppls 6(1): 57-58 (2005)

W11-P-009 Upregulation of the transcript level of P-selectin in the heart of C57Bl/6 (wild-type), Ldl-receptor and apoE knockout mice in response to Lps
, Atherosclerosis Suppls 6(1): 58-59 (2005)

W11-P-013 Analysis of genes associated with obesity in a population of French Canadian forest workers
, Atherosclerosis Suppls 6(1): 59-60 (2005)

W12-Is-002 Differences in secretory phospholipaseA2 type Iia and V enzymes function in lipoprotein metabolism and possible contribution to atherosclerosis
, Atherosclerosis Suppls 6(1): 60-61 (2005)

W12-P-002 Apob-100 Antigen structure of naturally occurring modified and enzymatically modified low density lipoprotein
, Atherosclerosis Suppls 6(1): 61-62 (2005)

W12-P-006 The impact of abnormalities of fatty acid metabolism in nonagenarians with coronary artery disease
, Atherosclerosis Suppls 6(1): 62-63 (2005)

W12-P-018 Lipid-peroxidation is enhanced in Sle patients and associated with arterial and renal disease manifestations
, Atherosclerosis Suppls 6(1): 65-66 (2005)

W12-P-023 The suppression of the inflammatory cytokines expression by natural substances
, Atherosclerosis Suppls 6(1): 66-67 (2005)

W12-P-026 Influence of ciglitazone on endothelial cells differentiation and on Bfgf and Vegf-dependent tubulogenesis
, Atherosclerosis Suppls 6(1): 67-68 (2005)

W12-P-030 Role of homocystinemia in the pathogenesis and outcome of premature myocardial infarction
, Atherosclerosis Suppls 6(1): 68-69 (2005)

W12-P-034 Ldl modification during atherosclerosis and diabetes
, Atherosclerosis Suppls 6(1): 69-70 (2005)

W12-P-038 Statin induced inhibition of Crp expression in primary human hepatocytes
, Atherosclerosis Suppls 6(1): 70-71 (2005)

W12-P-045 Endothelial function in patients with unstable angina
, Atherosclerosis Suppls 6(1): 72-73 (2005)

W12-P-049 Cyclooxygenase-2-derived prostacyclin restrains platelet thromboxane biosynthesis in toll-like receptor 4 polymorphisms
, Atherosclerosis Suppls 6(1): 73-74 (2005)

W12-P-053 Markers of inflammation-related parameters of malnutrition in hemodialysis patients
, Atherosclerosis Suppls 6(1): 74-75 (2005)

W12-P-057 Cd14 dependent adhesion of monocytes to oxidised Ldl and Hsp60 via lipid rafts
, Atherosclerosis Suppls 6(1): 75-76 (2005)

W12-P-061 Hypercholesterolemic Ldl increase endothelial Vegf and Vegfr-2 expression by inducing Hif-1alpha and superoxide production
, Atherosclerosis Suppls 6(1): 76-77 (2005)

W12-P-065 Ciprofibrate increases paraoxonase activity in patients with metabolic syndrome
, Atherosclerosis Suppls 6(1): 77-78 (2005)

W12-P-080 Comparative assessment of the inhibiting effect of captopril and of 4 antagonists of the angiotensin converting enzyme on Ldl oxidation by the myeloperoxidase
, Atherosclerosis Suppls 6(1): 81-82 (2005)

W12-P-084 Stereo-specific and redox-sensitive stimulation of monocyte adhesion to endothelial cells by homocysteine
, Atherosclerosis Suppls 6(1): 82-83 (2005)

W12-P-088 Immune inflammation and development of early atherosclerotic lesions in the aorta and pulmonary artery
, Atherosclerosis Suppls 6(1): 83-84 (2005)

W13-O-001 Fc receptor deficiency reduces macrophage accumulation and plaque formation in apoE knock-out mice
, Atherosclerosis Suppls 6(1): 84-85 (2005)

W13-P-002 Elevated haematocrit and reduced neutrophil counts in athero-susceptible C57Bl apoE-/-compared with athero-resistant C3H apoE-/-mice
, Atherosclerosis Suppls 6(1): 85-86 (2005)

W13-P-006 Expression and function of the epidermal growth factor receptor (Egfr) on human monocytes
, Atherosclerosis Suppls 6(1): 86-87 (2005)

W13-P-010 Angiogenic effects of Sdf-1-alphadepend on K+ channels, Ca2+ and No
, Atherosclerosis Suppls 6(1): 87-88 (2005)

W13-P-014 Antibodies to Il-8, Gro-alpha, Mcp-1 and their receptors Cxcr2 and Ccr2 inhibit the adhesion of U937 cells to human atherosclerotic plaques
, Atherosclerosis Suppls 6(1): 88-89 (2005)

W13-P-018 Toll-like receptor 4 expression on peripheral blood monocytes predicts the risk of coronary artery disease in patients with low C-reactive protein
, Atherosclerosis Suppls 6(1): 89-90 (2005)

W13-P-026 The potential role of advanced glycation end products (Ages) in vascular smooth muscle cell proliferation and restenosis in diabetic vasculopathy
, Atherosclerosis Suppls 6(1): 91-92 (2005)

W14-P-006 Genotype-specific increase in plasma concentrations of activated coagulation factor Vii in response to experimental inflammation. A link between infection and acute myocardial infarction
, Atherosclerosis Suppls 6(1): 94-95 (2005)

W15-Is-002 Role of farnesoid X receptor (Fxr) in control of plasma lipid levels
, Atherosclerosis Suppls 6(1): 95-96 (2005)

W15-P-001 Role of nuclear receptors in the molecular regulation of cholesterol homeostasis in cultured human hepatocytes
, Atherosclerosis Suppls 6(1): 96-97 (2005)

W15-P-005 Regulation of genes encoding intestinal cholesterol transporters by nuclear receptors in human Caco-2/Tc7 enterocytes
, Atherosclerosis Suppls 6(1): 97-98 (2005)

W16-O-003 Efficacy and safety of rosuvastatin 40 Mg in patients with severe type Iia and Iib hypercholesterolaemia
, Atherosclerosis Suppls 6(1): 99-100 (2005)

W16-P-002 Physician perceived barriers to optimal management of hyperlipidemia
, Atherosclerosis Suppls 6(1): 100-101 (2005)

W16-P-006 The efficacy and safety of statins for primary prevention of atherosclerosis in military air crew personnel
, Atherosclerosis Suppls 6(1): 101-102 (2005)

W16-P-010 Impact of the comercialized statins on the primary prevention of cardiovascular complications in Spain
, Atherosclerosis Suppls 6(1): 102-103 (2005)

W16-P-013 Postprandial lipid response of the orujo olive oil: Similarities and possible advantages compared with refined olive oil
, Atherosclerosis Suppls 6(1): 103-104 (2005)

W16-P-017 Cost-effectiveness of primary prevention of Cvd from the Uk Nhs perspective: A comparison of men and women with type 2 diabetes
, Atherosclerosis Suppls 6(1): 104-105 (2005)

W16-P-021 Effect of low dose of atorvastatin on hyperhomocysteinemic patients with associated combined hyperlipidemia
, Atherosclerosis Suppls 6(1): 105-106 (2005)

W16-P-025 Changes of plasma atherosclerosis risk factors' levels caused by estrogen replacement therapy
, Atherosclerosis Suppls 6(1): 106-107 (2005)

W16-P-029 Comparison of the efficacy and tolerability of rosuvastatin with atorvastatin in patients with hypercholesterolaemia: The discovery penta study
, Atherosclerosis Suppls 6(1): 107-108 (2005)

W16-P-033 Direct statin comparison of Ldl-Cvalues: An evaluation of rosuvastatin therapy (discovery Canada)
, Atherosclerosis Suppls 6(1): 108-109 (2005)

W16-P-037 Lipid metabolism in elderly patients suffering from hypertension drugs therapy
, Atherosclerosis Suppls 6(1): 109-110 (2005)

W16-P-041 Comparison of the efficacy of rosuvastatin versus other statins in achieving 2003 European Ldl-C goals
, Atherosclerosis Suppls 6(1): 110-111 (2005)

W16-P-048 Dependent the dose an activity of atorvastatin on oxidizability and atherogenic of serum of a blood in patients with early coronary artery disease
, Atherosclerosis Suppls 6(1): 112-113 (2005)

W16-P-052 Addition of ezetimibe to the treatment of type 2 diabetic patients with hyperlipidaemia, uncontrolled with statin treatment
, Atherosclerosis Suppls 6(1): 113-114 (2005)

W16-P-059 Antiatherogenic effects of phytoestrogens in postmenopausal women
, Atherosclerosis Suppls 6(1): 115-116 (2005)

W16-P-063 The lipid-altering effects of Inegy-Tm are consistent across gender, race, age, and baseline Ldl-C levels
, Atherosclerosis Suppls 6(1): 116-117 (2005)

W16-P-066 The effect of adherence to the Mediterranean diet on the severity and prognosis of acute coronary syndromes: The Greek study of Acs (the Greecs)
, Atherosclerosis Suppls 6(1): 117-118 (2005)

W16-P-071 Cv morbidity among Chd patients in Germany
, Atherosclerosis Suppls 6(1): 118-119 (2005)

W16-P-074 Duration of first visit to a lipid unit can affect patient's compliance
, Atherosclerosis Suppls 6(1): 119-120 (2005)

W16-P-078 Aminopeptidase N (Cd13) acts as aco-receptor for the enterocytic micellar cholesterol absorption through deep tubular invaginations
, Atherosclerosis Suppls 6(1): 120-121 (2005)

W16-P-082 Antiatherogenic potency of phytoestrogen-rich plants: The viewpoint for clinical implications
, Atherosclerosis Suppls 6(1): 121-122 (2005)

W17-O-004 Influence of cardiovascular risk factors on different vascular beds in women
, Atherosclerosis Suppls 6(1): 125-126 (2005)

W17-P-008 Phospholipid transfer protein activity and endothelial dysfunction in type 2 diabetes
, Atherosclerosis Suppls 6(1): 127-128 (2005)

W17-P-012 Relation between carotid intima-mediathickness and lipid profile at patients with metabolic syndrome
, Atherosclerosis Suppls 6(1): 128-129 (2005)

W17-P-016 Treatment with atorvastatin improved luminal diameter of brachial artery in patients with hypercholesterolemia
, Atherosclerosis Suppls 6(1): 129-130 (2005)

W17-P-020 Comparison of biochemical, functional and structural measurements of arterial wall properties in elderly men
, Atherosclerosis Suppls 6(1): 130-131 (2005)

T01-P-014 Postprandial lipaemia in men with metabolic syndrome and healthy men
, Atherosclerosis Suppls 6(1): 136-137 (2005)

T01-P-026 Prevalence of coronary events and cerebral infarction in male patients with the metabolic syndrome: The Kyushu lipid intervention study (Klis)
, Atherosclerosis Suppls 6(1): 139-140 (2005)

T02-P-007 Estimation of antioxidative effect of carvedilol in patients after myocardial infarction
, Atherosclerosis Suppls 6(1): 142-143 (2005)

T02-P-011 Transradial approach for coronary procedures The experience of Latvian Centre of Cardiology
, Atherosclerosis Suppls 6(1): 143-144 (2005)

T03-P-003 Drip paper-filtered and boiled and cotton-filtered coffee reduce lipid peroxidation and anthropometric parameters in primary hypercholesterolemia
, Atherosclerosis Suppls 6(1): 146-147 (2005)

T03-P-007 Exercise-training accelerates low-density lipoprotein metabolism in hypercholesterolemia
, Atherosclerosis Suppls 6(1): 147-148 (2005)

T03-P-019 Changes of cholesterol metabolism in nonagenarians
, Atherosclerosis Suppls 6(1): 150-151 (2005)

T03-P-023 Distribution and prevalence of subclinical atherosclerosis as determined by carotid intima media thickness and plaque index in early postmenopausal Chinese women in Hong Kong
, Atherosclerosis Suppls 6(1): 151-152 (2005)

T04-P-004 Direct atherogenic effect of homocysteine in cultured human intimal cells
, Atherosclerosis Suppls 6(1): 152-153 (2005)

T04-P-008 The impact of hs-crp on risk evaluation in hypertensive patients: Lessons learned from iceberg study
, Atherosclerosis Suppls 6(1): 153-154 (2005)

T04-P-012 High prevalence of different types ofdyslipidemia in individuals from an urban area of the state of Sao Paulo, Brazil
, Atherosclerosis Suppls 6(1): 154-155 (2005)

T04-P-016 Plasma Paf-Acetylhydrolase (Lp-Pla2) activity as a marker of small-dense Ldl in subjects at median cardiovascular risk
, Atherosclerosis Suppls 6(1): 155-156 (2005)

T04-P-020 Riga ncb and Riga I Ncb Studies: The Effect of Barotrauma reduction on neointimal proliferation after regular and direct stenting
, Atherosclerosis Suppls 6(1): 156-157 (2005)

T04-P-024 Serum apolipoprotein al (Apoa1) levels are strong predictors of atherosclerotic cardiovascular disease in patients on chronic haemodialysis
, Atherosclerosis Suppls 6(1): 157-158 (2005)

T04-P-028 Stroke patient models based on supervised inductive machine learning
, Atherosclerosis Suppls 6(1): 158-159 (2005)

T04-P-031 Effect of maternal diet during pregnancy on insulin levels and birth weight of neonates
, Atherosclerosis Suppls 6(1): 159-160 (2005)

T04-P-035 Pancreatitis frequency in Hiv-positive and Hiv-negative patients with hypertriglyceridemia
, Atherosclerosis Suppls 6(1): 160-161 (2005)

T04-P-039 The role of plasma homocysteine levelon collateral status in single-vessel chronic total occlusion
, Atherosclerosis Suppls 6(1): 161-162 (2005)

T04-P-043 Interrelationship of classical and emergent risk factors with genetic variants relevant to coronary heart disease
, Atherosclerosis Suppls 6(1): 162-163 (2005)

T04-P-047 Risk factors for atherosclerosis in patients with obstructive sleep apnea syndrome
, Atherosclerosis Suppls 6(1): 163-164 (2005)

T05-P-004 Association between C-Reactive protein and metabolic/haemodynamic parameters
, Atherosclerosis Suppls 6(1): 164-165 (2005)

T06-P-003 Plasma kinetics of a lipid emulsion resembling low-density lipoprotein in morbid obesity
, Atherosclerosis Suppls 6(1): 165-166 (2005)

T06-P-007 Phospholipid transfer protein (Pltp) is present in human tear fluid
, Atherosclerosis Suppls 6(1): 166-167 (2005)

T07-P-008 Genetic risk factors for coronary heart disease in patients with familial hypercholesterolemia
, Atherosclerosis Suppls 6(1): 172-173 (2005)

Mo-P5:307 Effect of vitamin E supplementation on immune responses to prolonged exercise
, Atherosclerosis Suppls 7(3): 113-114 (2006)

Tu-P7:194 Apolipoprotein Ci stimulates the inflammatory response to lipopolysaccharide in mice and humans
, Atherosclerosis Suppls 7(3): 227-228 (2006)

Tu-P8:327 Mouse, but not human, macrophages activate Nfkappab P50 homodimers in response to low extracellular Ph to limit Tnf-alpha induced cytokine secretion
, Atherosclerosis Suppls 7(3): 256-257 (2006)

Tu-P10:477 Vascular chimerism of human cardiac allograft is the result of inflammatory response
, Atherosclerosis Suppls 7(3): 289-290 (2006)

We-P11:271 Humoral response against high density lipoproteins (Hdl) in normal population
, Atherosclerosis Suppls 7(3): 405-406 (2006)

Th-P16:337 Nicotinic acid: A woman's drug
, Atherosclerosis Suppls 7(3): 567-568 (2006)

Th-P16:410 Beneficial effects of simvastatin (Vasilip) on thrombogenic response an lipid profile in subjects with Chd
, Atherosclerosis Suppls 7(3): 583-584 (2006)

Th-P17:419 The apolipoprotein E gene promoter (491 A/T) polymorphism determines triacylglycerol plasma concentration in response to dietary fat
, Atherosclerosis Suppls 7(3): 585-586 (2006)

Wo1-Or-6 Long-Term Treatment with Folic Acid, Vitamin B6 and B12 does not Improve Vascular Structure or Function: A Randomized Controlled Trial
, Atherosclerosis Suppls 8(1): 1-2 (2007)

Wo8-Or-5 a 5-Year Perspective Study on Ultrasound Carotid Intima-Media Thickness in Grade I Hypertensives
, Atherosclerosis Suppls 8(1): 8-9 (2007)

Wo9-Or-5 Insulin Resistance Reduces the Contribution of Systemic Plasma Non-Esterified Fatty Acids into Very Low-Density Lipoprotein Triacylglycerol
, Atherosclerosis Suppls 8(1): 9-10 (2007)

Wo10-Or-5 increased Lipolysis by Secretory Phospholipase A2 Group V of Lipoproteins from Subjects with type 2 Diabetes and the Metabolic Syndrome
, Atherosclerosis Suppls 8(1): 10-11 (2007)

Wo12-Or-4 Association of Alox15 Gene Polymorphisms with Prevalence and Progression of Coronary Artery Calcification: The Cardia Study
, Atherosclerosis Suppls 8(1): 12-13 (2007)

Wo13-Or-4 increased Atherosclerotic Lesions and Th17 cells in Interleukin-18 Deficient Apolipoprotein E-Knockout Mice Fed High-Cholesterol Diet
, Atherosclerosis Suppls 8(1): 13-14 (2007)

Wo14-Or-4 Thiol Oxidative Stress in Macrophage Injury and Atherosclerotic Lesion Development in Ldl Receptor-Deficient Mice
, Atherosclerosis Suppls 8(1): 14-15 (2007)

Wo15-Or-4 a Novel Loss of Function Mutation of Pcsk9 Gene in Caucasians with low Plasma Ldl-Cholesterol
, Atherosclerosis Suppls 8(1): 15-16 (2007)

Wo16-Or-4 Association Of Serum Homocysteine, Folate And Mthfr C677T Genotypes With Early Atherosclerosis. Results From The Cyprus Study
, Atherosclerosis Suppls 8(1): 16-17 (2007)

Po1-17 effect of Troglitazone and its Blocker (Sr-202) on Nitric Oxide Production and Lipolysis in Adipocyte Culture
, Atherosclerosis Suppls 8(1): 22-23 (2007)

Po1-21 Sources of Fatty Acids for 3-Hydroxybutyrate Production Differ during Short-Term Fasting in Men and Women
, Atherosclerosis Suppls 8(1): 23-24 (2007)

Po2-25 the Mechanism of the Assembly of Cytosolic Lipid Droplets
, Atherosclerosis Suppls 8(1): 24-25 (2007)

Po2-29 Deficiency of Macrophage Phospholipid Transfer Protein Protects against Atherosclerotic Lesion Development
, Atherosclerosis Suppls 8(1): 25-26 (2007)

Po2-42 Development and Application of a Novel Mouse Apoe Elisa Method
, Atherosclerosis Suppls 8(1): 28-29 (2007)

Po2-55 Apoe/Ldl Receptor-Double-Knockout Mice: An Animal Model for the Study of Statins effects in Atherogenesis
, Atherosclerosis Suppls 8(1): 31-32 (2007)

Po3-59 Smoking, Borderline Ldl Levels and Renal small Vessel Disease of Women with Overweight
, Atherosclerosis Suppls 8(1): 32-33 (2007)

Po3-68 Immune Complexes and Lipid Spectrum in Patients with Stroke
, Atherosclerosis Suppls 8(1): 34-35 (2007)

Po3-77 Particle Profiler: A Model Analysis of Lipoprotein Delipidation
, Atherosclerosis Suppls 8(1): 36-37 (2007)

Po3-81 Parabolic relation between Plasma Triglycerides and Ldl-Cholesterol in Familial Combined Hyperlipidemia: The Multiple-Type Hyperlipidemia Explained?
, Atherosclerosis Suppls 8(1): 37-38 (2007)

Po3-85 Evaluation of the Ability of Simple Lipid Measures to Predict the Presence of Small, Dense Ldl Particles
, Atherosclerosis Suppls 8(1): 38-39 (2007)

Po4-94 Native and Oxidized low Density Lipoprotein Modulate Adrenal Steroidogenesis via Extracellular Signal-Regulated Kinase
, Atherosclerosis Suppls 8(1): 40-41 (2007)

Po4-103 Inhibition of Cholesterol Biosynthesis Affects Lipid Raft/Caveolae and Signal Transduction in Adipogenesis
, Atherosclerosis Suppls 8(1): 42-43 (2007)

Po5-107 The Interaction Between Adherence To The Mediterranean Diet And Methylenetetrahydrofolate Reductase C677T Mutation On Homocysteine Concentrations
, Atherosclerosis Suppls 8(1): 43-44 (2007)

Po5-111 C242T Polymorphism Of Nadph Oxidase P22Phox Gene Predicts Major Cardiovascular Events (Mace) In High-Risk Individuals
, Atherosclerosis Suppls 8(1): 44-45 (2007)

Po5-115 Direct Quantitative Assessment of Mutant Allele in Mitochondrial Genome in Atherosclerotic Lesion of Human Aorta
, Atherosclerosis Suppls 8(1): 45-46 (2007)

Po5-119 Mutations in the Cetp Gene in Italian Subjects with Hyperalphalipoproteinemia
, Atherosclerosis Suppls 8(1): 46-47 (2007)

Po5-123 Association Of Lpl Variants, D9N And N291S, And Apo E Polymorphisms With Hypertriglyceridemia In A Mediterranean Spanish Working Population
, Atherosclerosis Suppls 8(1): 47-48 (2007)

Po5-126 Combined Effect Of K121Q Of Enpp1 (Pc-1) And Q84R Of Trib3 On Age At Myocardial Infarction In Type 2 Diabetic Patients
, Atherosclerosis Suppls 8(1): 48-49 (2007)

Po5-147 Association Of Paraoxonase 1 Poly- Morphism With Alzheimer'S Disease And Increased Plasma Levels Of Oxidized Ldl
, Atherosclerosis Suppls 8(1): 53-54 (2007)

Po5-151 Angiotensin Ii and Ace Polymorphisms in relation to Fasting and Postprandial Lipids and Determinants of the Metabolic Syndrome
, Atherosclerosis Suppls 8(1): 54-55 (2007)

Po5-155 Polymorphism Glu298Asp Of Endothelial Nitric Oxide Synthase Gene And Its Influence On Incidence Of Atherosclerosis In Patients With Arterial Hypertension
, Atherosclerosis Suppls 8(1): 55-56 (2007)

Po5-159 The 11377 C>G Promoter Variant Of The Adiponectin Gene, Prevalence Of Coronary Atherosclerosis, And Incidence Of Vascular Events In Men
, Atherosclerosis Suppls 8(1): 56-57 (2007)

Po6-163 Profiling of Macrophage Gene Expression in Response to Ldl Particles Modified by Human Group X Secreted Phospholipase A2
, Atherosclerosis Suppls 8(1): 57-58 (2007)

Po6-167 Cb1 Cannabinoid Receptors Regulate the Fatty Acid Metabolism in Morbidly Obese Persons
, Atherosclerosis Suppls 8(1): 58-59 (2007)

Po6-176 Human Evidence for the Involvement of Insig-2 in the Adipose Tissue Metabolism
, Atherosclerosis Suppls 8(1): 60-61 (2007)

Po7-179 Grape Juice Polyphenols Downregulate Nicotinamide Adenine Dinucleotide Phosphate Oxidase Subunit Expression in Circulating Blood cells
, Atherosclerosis Suppls 8(1): 61-62 (2007 )

Po7-183 Effects Of Cyp2D6 Polymorphism On Response To Rosuvastatin In Chinese Patients
, Atherosclerosis Suppls 8(1): 62-63 (2007)

Po8-195 Interferon-Gamma Contributes to Neointimal Proliferation following Arterial Angioplasty in a Mouse Model
, Atherosclerosis Suppls 8(1): 65-66 (2007)

Po9-200 Inflammation Markers and Mmps in Nondiabetic and Diabetic Subjects during Ogtt
, Atherosclerosis Suppls 8(1): 66-67 (2007)

Po9-204 Activated Mast cells Induce Endothelial cell Apoptosis by a Combined Action of Chymase and Tnf-Alpha
, Atherosclerosis Suppls 8(1): 67-68 (2007)

Po9-217 Palmitate Induces Proinflammatory Cytokine Secretion in Human Macrophages via Activation of P38 and Jnk Kinases
, Atherosclerosis Suppls 8(1): 70-71 (2007)

Po9-221 Pro-Inflammatory effect of Oxysterols: Up-Regulation of Mcp-1 in Macrophage cells
, Atherosclerosis Suppls 8(1): 71-72 (2007)

Po9-225 Inhibition of Platelet Activation by Peptide Analogues of the Intracellular Domain of Beta 3 Subunit of the Platelet Integrin Receptor
, Atherosclerosis Suppls 8(1): 72-73 (2007)

Po9-229 Impairment of no and Upregulation of Cox-2/Pgi2 and Edhf Pathways in Apoe/Ldlr / Mice; Relationship with Development of Atherosclerotic Plaques
, Atherosclerosis Suppls 8(1): 73-74 (2007)

Po9-234 Nrf2 Down-Regulates Thioredoxin Interacting Protein (Txnip) Expression
, Atherosclerosis Suppls 8(1): 74-75 (2007)

Po9-242 Presence of Igg Antibodies to Carbamylated Proteins Are Related to Antibodies Binding to Apoptotic cells
, Atherosclerosis Suppls 8(1): 76-77 (2007)

Po9-246 Human Paraoxonase 2: An Endogenous Enzyme as Defense System against Vascular Oxidative Stress and Endoplasmic Reticulum Stress-Induced Apoptosis
, Atherosclerosis Suppls 8(1): 77-78 (2007)

Po9-250 Diurnal Variations of Soluble Cd40 Ligand Serum Levels in Patients with St-Segment Elevation Myocardial Infarction
, Atherosclerosis Suppls 8(1): 78-79 (2007)

Po9-261 high Sensitivity C-Reactive Protein Levels and Micromacrovascular Elasticity
, Atherosclerosis Suppls 8(1): 81-82 (2007)

Po9-269 Proatherogenic Bacteria Induce an Inflammatory Response in Cultured Mast cells
, Atherosclerosis Suppls 8(1): 83-84 (2007)

Po10-276 the Role of Paf-Acetylhydrolase in the Development of Atherosclerosis
, Atherosclerosis Suppls 8(1): 85-86 (2007)

Po10-284 Inhibition Of The Mpo/H2O2/Chloride Dependent Ldl Oxidation Assessed By In Vitro, Elisa And Cell Tests
, Atherosclerosis Suppls 8(1): 87-88 (2007)

Po10-293 Co-Supplementation of Copper and Zinc Has a different effect on Atherosclerosis in Iron-Overload Hypercholesterolemic Rabbits
, Atherosclerosis Suppls 8(1): 89-90 (2007)

Po11-301 Expression of Cytokeratins inside Atherosclerotic Lesions of different Anatomic Regions
, Atherosclerosis Suppls 8(1): 91-92 (2007)

Po11-305 Association of Serum Paraoxonase with Carotid Atherosclerosis
, Atherosclerosis Suppls 8(1): 92-93 (2007)

Po11-309 Arterial Wall Remodelling and the Ras. Implicated in Aaa Disease
, Atherosclerosis Suppls 8(1): 93-94 (2007)

Po11-313 Suppression of 15-Hydroxyprostaglandin Dehydrogenase as a Basis of Atherosclerotic Plaque Instability in Humans
, Atherosclerosis Suppls 8(1): 94-95 (2007)

Po12-317 Activation State of Neutrophils in Patients with Stable Coronary Artery Disease
, Atherosclerosis Suppls 8(1): 95-96 (2007)

Po12-322 effects of Phosphatidylethanol on Endosomes in Cultured Human Endothelial cells
, Atherosclerosis Suppls 8(1): 96-97 (2007)

Po13-336 Patients with Coronary and Supraaortic Artery Atherosclerotic Disease Have a high Prevalence of Renal Artery Stenosis
, Atherosclerosis Suppls 8(1): 99-100 (2007)

Po13-339 Beneficial effects of 1-Year Optimal Medical Treatment with and without Additional Pta on Inflammation in Patients with Pad
, Atherosclerosis Suppls 8(1): 100-101 (2007)

Po13-344 Cardiochek Pa Cholesterol-Testing Device Compared to Diagnostic Laboratory Method
, Atherosclerosis Suppls 8(1): 101-102 (2007)

Po13-348 Evidence-Based Cardiovascular Therapies and Therapeutic Goals in Patients with Coronary Disease and Chronic Kidney Disease Attended in Primary Care
, Atherosclerosis Suppls 8(1): 102-103 (2007)

Po13-352 Verification of a Computer Controlled Model for Ldl-Apheresis Optimization in Clinical Practice
, Atherosclerosis Suppls 8(1): 103-104 (2007)

Po13-356 Main Features of the Care of Patients with Multiplex Cerebral Infarction
, Atherosclerosis Suppls 8(1): 104-105 (2007 )

Po14-360 Immunocytochemical and Ultrastructural Analysis of Aortic Wall Remodeling
, Atherosclerosis Suppls 8(1): 105-106 (2007)

Po14-372 Adiponectin and Carotid Imt in 24-39 Years Old Finns
, Atherosclerosis Suppls 8(1): 108-109 (2007)

Po14-376 Myocardial Functional And Textural Findings Of The Right Ventricle And Their Association With Cellular Adhesion Molecules In Behcet'S Disease
, Atherosclerosis Suppls 8(1): 109-110 (2007)

Po14-380 Carotid Dilatation and Cholesterolemia at Hypertensive Patients as Predictor for Stroke
, Atherosclerosis Suppls 8(1): 110-111 (2007)

Po14-395 Prevalence of Subclinical Peripheral Atherosclerosis in Rheumatoid Arthritis Patients
, Atherosclerosis Suppls 8(1): 114-115 (2007)

Po15-400 Vascular Smooth Muscle cell Survival is Preserved by in Vivo no Donor Treatment
, Atherosclerosis Suppls 8(1): 115-116 (2007)

Po15-404 Equol Production Capability is Associated with Favorable Endothelial Function in Postmenopausal Women using Tibolone
, Atherosclerosis Suppls 8(1): 116-117 (2007)

Po15-408 the effect of Aspirin on Serum Vascular Endothelial Growth Factor and Nitric Oxide Concentrations in High-Cholesterol Fed Rabbits
, Atherosclerosis Suppls 8(1): 117-118 (2007)

Po15-412 Periodontal Care may Improve Endothelial Dysfunction
, Atherosclerosis Suppls 8(1): 118-119 (2007)

Po15-416 Brachial Endothelial Function in Subjects with Familial Combined Hyperlipidemia and its Relationships to Carotid Artery Intima-Media Thickness
, Atherosclerosis Suppls 8(1): 119-120 (2007)

Po15-421 Assymetric Dimethylarginine in Patients with Severe Peripheral Artery Disease
, Atherosclerosis Suppls 8(1): 120-121 (2007)

Po16-425 Cardiovascular Risk, Cholesterol Goal Attainment, and Lipid-Lowering Eligibility in Chile. Findings from the First National Health Survey
, Atherosclerosis Suppls 8(1): 121-122 (2007)

Po16-430 Association of Smoking, Metalloproteinases and Cardiovascular Risk Factors in Healthy Middle-Aged Subjects
, Atherosclerosis Suppls 8(1): 122-123 (2007)

Po16-434 Redox Ranking of Plasma Ischemia Modified Albumin (Ima), Hscrp and Chlamydophila Pneumoniae Seropositivity. Longitudinal Study in Pvd Patients
, Atherosclerosis Suppls 8(1): 123-124 (2007)

Po16-438 Lipid Management and Ldl-C Goal Attainment in Clinical Practice in Singapore
, Atherosclerosis Suppls 8(1): 124-125 (2007)

Po16-442 Modeling Reductions in Cholesterol and Cardiovascular Events in Cohort of Argentinean Patients Switched from Statin Monotherapy to Ezetimibe/Simvastatin
, Atherosclerosis Suppls 8(1): 125-126 (2007)

Po16-446 Sustained Suboptimal Secondary Prevention of Coronary Artery Disease in type 2 Diabetes: An Analysis of 41300 Patients over 3 Years
, Atherosclerosis Suppls 8(1): 126-127 (2007)

Po16-459 Tgf-Beta1 is a Marker for left Ventricular Hypertrophy in Hypertensive Subjects in a General Population
, Atherosclerosis Suppls 8(1): 129-130 (2007)

Po16-464 Control of Cardiovascular Risk Factors in Outpatients with Atherothrombosis in Greece
, Atherosclerosis Suppls 8(1): 130-131 (2007)

Po16-468 Ethnic Differences in Rates of Incident Myocardial Infarction in Patients with Hypertension Are Explained by an Excess of Diabetes
, Atherosclerosis Suppls 8(1): 131-132 (2007)

Po16-471 Lifestyle Screening Study in Teens Predictor for Atherosclerosis
, Atherosclerosis Suppls 8(1): 132-133 (2007)

Po16-476 Dislipemia Prevalence in a Labor Population. Ibermutuamur Cardiovascular Investigation Plan
, Atherosclerosis Suppls 8(1): 133-134 (2007)

Po17-488 high Cardio-Ankle Vascular Index (Cavi) can Predict the Development of Carotid Atherosclerosis
, Atherosclerosis Suppls 8(1): 136-137 (2007)

Po17-495 Value of Doppler Ultrasonography in Renal Artery Stenosis Recognition
, Atherosclerosis Suppls 8(1): 138-139 (2007)

Po17-499 Mri Based Classification of Carotid Stenosis: A Promising Tool for Detection of Unstable Lesions
, Atherosclerosis Suppls 8(1): 139-140 (2007)

Po17-503 Comparison of Coronary Artery Disease Risk Factors and Atherosclerosis Progression with Exercise Tolerance in Patients with Diabetes Mellitus 2
, Atherosclerosis Suppls 8(1): 140-141 (2007)

Po19-519 Plasma Il-5 Levels Are Associated with Antibodies to Oxidized Ldl and Subclinical Atherosclerosis in Humans
, Atherosclerosis Suppls 8(1): 144-145 (2007)

Po19-523 Relationship between Ankle-Brachial Index and Chronic Renal Disease in Hypertensive Subjects with no Known Cardiovascular Disease
, Atherosclerosis Suppls 8(1): 145-146 (2007)

Po19-527 Role of the Arterial Stenosis in an Atherosclerosis
, Atherosclerosis Suppls 8(1): 146-147 (2007 )

Po19-531 Association of Human Cartilage Glycoprotein-39 Levels with the Extent of Coronary Artery Disease in Patients Undergoing Coronary Angiography
, Atherosclerosis Suppls 8(1): 147-148 (2007)

Po19-539 Inverse relation between Serum Cholesterol Concentration and left Ventricular Function in Young Hypertensive Patients
, Atherosclerosis Suppls 8(1): 149-150 (2007)

Po19-552 Risk Factors of Atherosclerosis and Coagulation Disorders in Patients Treated for Epilepsy
, Atherosclerosis Suppls 8(1): 152-153 (2007)

Po19-560 Blood-Borne Virus and Atherosclerosis
, Atherosclerosis Suppls 8(1): 154-155 (2007)

Po19-565 the Regulatory Role of C-Reactive Protein (Crp) on Platelet Activation
, Atherosclerosis Suppls 8(1): 155-156 (2007)

Po19-569 high Levels of Fibrinogen Are Associated with Poor Short-Term Prognosis in Patients with Acute Ischaemic Stroke
, Atherosclerosis Suppls 8(1): 156-157 (2007)

Po19-573 Emerging Cardiovascular Risk Biomarkers in type 2 Diabetic Patients with Subclinical Atherosclerotic Disease
, Atherosclerosis Suppls 8(1): 157-158 (2007)

Po19-577 Serum Adipokines Are Associated with Cholesterol Metabolism in Metabolic Syndrome
, Atherosclerosis Suppls 8(1): 158-159 (2007)

Po19-582 Elevated Serum Neopterin Levels Predict Adverse Cardiac Events in Patients with Non-St-Segment Elevation Acute Coronary Syndromes. The Siesta Study
, Atherosclerosis Suppls 8(1): 159-160 (2007)

Po19-586 Evidence at Autopsy of Spasm in the right Distal Coronary Artery in Cases of Coronary Heart Disease with Sudden Death
, Atherosclerosis Suppls 8(1): 160-161 (2007)

Po19-591 Interleukin 6 is Associated with Restenosis after Implantation of Both Bare-Metal and Drug-Eluting Coronary Stents
, Atherosclerosis Suppls 8(1): 161-162 (2007)

Po20-595 Short Term effect of four different Macronutrient Oral Loads on Metabolic Profile and Flow Mediated Vasodilatation in Healthy Young Men
, Atherosclerosis Suppls 8(1): 162-163 (2007)

Po20-600 Mufa-Rich Diet Prevents Central Body Fat Distribution and Decreased Posprandial Adiponectin Expression induced by Carbohydrate-Rich Diet
, Atherosclerosis Suppls 8(1): 163-164 (2007)

Po20-609 Association of Drinking Pattern with the Prevalence of Metabolic Syndrome, Diabetes, Coronary Heart Disease, Stroke and Peripheral Arterial Disease
, Atherosclerosis Suppls 8(1): 165-166 (2007)

Po20-613 the Pleiotropic effects of Anthocyanins from Chokeberry in Patients with Metabolic Syndrome
, Atherosclerosis Suppls 8(1): 166-167 (2007)

Po20-617 effects of Ferrosuper (Driatec) Supplementation on Lipid and Redox Parameters in Healthy Subjects
, Atherosclerosis Suppls 8(1): 167-168 (2007)

Po20-621 Dietary low Sodium Increases Plasma Inflammatory Markers in Hypertensive Patients
, Atherosclerosis Suppls 8(1): 168-169 (2007)

Po21-638 the Metabolic Syndrome is Associated with Early Mortality in Acute Coronary Syndrome
, Atherosclerosis Suppls 8(1): 172-173 (2007)

Po21-647 Waist Circumference like a Childhood Obesity Index
, Atherosclerosis Suppls 8(1): 174-175 (2007)

Po21-652 the Body Mass Index as Predictor of Poor Outcomes in Chronic Heart Failure Patients and Preserved left Ventricular Systolic Function
, Atherosclerosis Suppls 8(1): 175-176 (2007)

Po21-656 Evaluation of Anthropometric Parameters as Risk Factors for Atherosclerosis in Children
, Atherosclerosis Suppls 8(1): 176-177 (2007)

Po22-689 effects of Rosiglitazone on the Serum Paraoxonase Activity and Metabolic Parameters in Patients with type 2 Diabetes
, Atherosclerosis Suppls 8(1): 184-185 (2007)

Po22-693 Inhibition of Plasma Oxidation and Reduction of Leukotriene B4 Release after Oral Administration of Agi-1067, a Novel Anti-Atherosclerotic Agent
, Atherosclerosis Suppls 8(1): 185-186 (2007)

Po22-714 the effect of Moxonidine in Comparison with Prestarium on Parameters of Lipid Metabolism in Postmenopausal Women with Hypertension
, Atherosclerosis Suppls 8(1): 190-191 (2007)

Po22-718 Comparison of effects of Amlodipine and Angiotensin Receptor Blockers on the Intima-Media Thickness of Caroitd Arterial Wall (Aaa Study: Amlodipine Vs Arb in Atherosclerosis Study)
, Atherosclerosis Suppls 8(1): 191-192 (2007)

Po22-722 Pharmacological Inhibition of Cholesteryl Ester Transfer Protein Attenuates Atherogenic Features of Postprandial Lipemia in type Iib Hyperlipidemia
, Atherosclerosis Suppls 8(1): 192-193 (2007)

Po23-734 Influence of Age, Gender, and Ethnicity on Treatment effects in the Vytal Trial of Ezetimibe/Simvastatin Vs. Atorvastatin in type 2 Diabetics
, Atherosclerosis Suppls 8(1): 195-196 (2007)

Po23-738 effects of Rosuvastatin and Atorvastatin on Low-Density and high Density Lipoprotein Particle Concentrations in Patients with Metabolic Syndrome
, Atherosclerosis Suppls 8(1): 196-197 (2007)

Po23-742 Trial Based Economic Evaluation of Intensive Atorvastatin Compared to Standard Simvastatin in the Ideal Trial
, Atherosclerosis Suppls 8(1): 197-198 (2007)

Po23-750 Decreased Skeletal Muscle Mitochondrial DNA in Patients Treated with High-Dose Simvastatin
, Atherosclerosis Suppls 8(1): 199-200 (2007)

Po23-760 effect of Ezetimibe plus Simvastatin (Eze/Simva) on Attainment of Ldl-C Treatment Targets in Hypercholesterolemic Patients
, Atherosclerosis Suppls 8(1): 202-203 (2007)

Po23-767 the effect of Atorvastatin Treatment on Serum Levels of Lipids and C-Reactive Protein in Patients with Acute Coronary Syndrome
, Atherosclerosis Suppls 8(1): 204-205 (2007)

Po23-775 effect of Co-Administration of Ezetimibe/Simvastatin and Fenofibrate on Apolipoproteins (A-I, B, and Ciii) in Patients with Mixed Hyperlipidemia
, Atherosclerosis Suppls 8(1): 206-207 (2007)

Po23-784 effects of Prolonged Treatment with Atorvastatin and Rosuvastatin on Intima Media Thickness and Interleukins, C-Reactive Protein, D-Dimers and Protein-C
, Atherosclerosis Suppls 8(1): 208-209 (2007)

Po23-788 effects of Co-Administered Ezetimibe/Simvastatin and Fenofibrate on Lipoprotein Subclasses and Ldl Size Pattern in Patients with Mixed Hyperlipidemia
, Atherosclerosis Suppls 8(1): 209-210 (2007)

Yi-793 effect of Apolipoprotein M on Modulation of Hdl in Apom Transgenic and Apom Deficient Mice
, Atherosclerosis Suppls 8(1): 211-212 (2007)

Yi-797 Lectin-Like Oxidized-Ldl Receptor-1 (Lox-1) and Nitric Oxide Sinthase (Nos) Polymorphisms Influences Atorvastatin Antithrombotic Action and Cardiovascular Event Rate
, Atherosclerosis Suppls 8(1): 212-213 (2007)

Yi-806 Pcsk9 Gene Analysis in Portuguese Patients with Familial Hypercholesterolemia
, Atherosclerosis Suppls 8(1): 214-215 (2007)

Yi-810 Alloimmune Response Induces Hif-1 Activation in Vascular and Inflammatory cells of Transplanted Hearts Possible Link to Cardiac Allograft Vasculopathy
, Atherosclerosis Suppls 8(1): 215-216 (2007)

Yi-814 Non-Typical Antigen-Presenting cells in Subendothelial Intima of Human Aorta
, Atherosclerosis Suppls 8(1): 216-217 (2007)

Yi-822 Ebm Based Approach to Angiotensin Ii Receptor Evaluation and Management
, Atherosclerosis Suppls 8(1): 218-219 (2007)

Yi-843 Patients with Metabolic Syndrome Have Higher Serum Gamma-Glutamyltransferase Activity
, Atherosclerosis Suppls 8(1): 223-224 (2007)

Yi-851 Dose-Dependent effect of Rosuvastatin on Apolipoprotein B-100 Kinetics in the Metabolic Syndrome
, Atherosclerosis Suppls 8(1): 225-226 (2007)

Lb-Po-852 Free Cholesterol Content of Erythrocyte Membranes is increased in Patients with Acute Coronary Syndrome. An Additional Detrimental effect of Erythrocyte Derived Cholesterol that Triggers Plaque Instability?
, Atherosclerosis Suppls 8(1): 228-229 (2007)

Lb-Po-860 Comprehensive Metabolomic Characterisation of Lipoprotein Fractions Reveals Differential Lipoprotein-Specific Regulation of Xenobiotic and Pro-Inflammatory Metabolites in Patients with Metabolic Syndrome
, Atherosclerosis Suppls 8(1): 230-231 (2007)

Lb-Po-868 Anti-Atherogenic Potential of Relm Alpha Anti-Inflammatory Properties
, Atherosclerosis Suppls 8(1): 232-233 (2007)

D 004 Cardiac Alterations in Japanese-Brazilians with Diabetes and Metabolic Syndrome
, Atherosclerosis Suppls 8(3): 1-2 (2007)

H 004 Fluvastatin Attenuates Blood Pressure Responses to Exercise but not in Abpm in Hypertensive and Dyslipidemic Subjects
, Atherosclerosis Suppls 8(3): 5-6 (2007)

H 007 Metabolic Syndrome in a high Cardiovascular Risk Outpatient Clinic
, Atherosclerosis Suppls 8(3): 6-7 (2007)

H 011 Metabolic effects of Antyhypertensive Agents in Normoglycemic, Normolipidemic Hypertensive Patients
, Atherosclerosis Suppls 8(3): 7-8 (2007)

H 018 Chronic Kidney Disease is an Independent Predictor of In-Hospital Death in Patients with Myocardial Infarction
, Atherosclerosis Suppls 8(3): 9-10 (2007)

H 036 Cardiovascular Risk Stratification in Patients with Refractory Arterial Hypertension
, Atherosclerosis Suppls 8(3): 14-15 (2007)

H 040 Plasma Cholesterol is an Independent Modulator for the Rest Blood Pressure Regulation in Children and in Identical Twins
, Atherosclerosis Suppls 8(3): 15-16 (2007)

L 008 Achievement of Target Ldl-Cholesterol Levels in a Tertiary Hospital Outpatient Clinic
, Atherosclerosis Suppls 8(3): 18-19 (2007)

L 015 low Titers of Human Antioxidized Ldl Autoantibodies Are Associated with Unstable Coronary Disease
, Atherosclerosis Suppls 8(3): 20-21 (2007)

L 019 Ldl Receptor Deficient Mice Develop Atherosclerosis Independently of high Fat and high Cholesterol Diets
, Atherosclerosis Suppls 8(3): 21-22 (2007)

L 027 Percutaneous Coronary Intervention in 2006: Private X Public System Analyzes
, Atherosclerosis Suppls 8(3): 23-24 (2007)

L 034 Evaluation of Reticulated Platelets and Platelet Activation in Patients with Dyslipidemia
, Atherosclerosis Suppls 8(3): 25-26 (2007)

L 038 Atherosclerotic Lesions Express Mrna For Il-17, Il-17R, Il-23 And Il-23R
, Atherosclerosis Suppls 8(3): 26-27 (2007)

L 042 Plant Sterols Have Additional effects to Ezetimibe on Reducing Ldl Cholesterol of Coronary Patients Already Taking Statins but not Reaching Lipid Goals
, Atherosclerosis Suppls 8(3): 27-28 (2007)

L 046 Subclinical Atherosclerosis Markers do not Correlate among Themselves in Familial Hypercholesterolemia Subjects without Use of Statin
, Atherosclerosis Suppls 8(3): 28-29 (2007)

L 053 Characterization of Oxidized Ldl by the Z-Scan Technique in Patients with Metabolic Syndrome after an Acute Coronary Event
, Atherosclerosis Suppls 8(3): 30-31 (2007)

L 057 Higher Uric Acid Was Detect in Female Ambulatory Patients with Laboratorial Exams Which Indicate the Presence of Metabolic Syndrome
, Atherosclerosis Suppls 8(3): 31-32 (2007)

L 065 Comparison of the Lipid Profile of Women during the Pre-And Post-Menopausal Period
, Atherosclerosis Suppls 8(3): 33-34 (2007)

Histamine H1 Receptor is Required for Atherogenesis
, Atherosclerosis Suppls 9(1): 1-2 (2008)

Effect of Experimental Hyperleptinemia on Plasma Paraoxonase 1 (Pon1) Activity toward Homocysteine Thiolactone and N-Homocysteinylation of Plasma Proteins
, Atherosclerosis Suppls 9(1): 2-3 (2008)

The Prothrombotic Phenotype Observed in Niddm is Independent of Blood Glucose Levels
, Atherosclerosis Suppls 9(1): 3-4 (2008)

Endothelial cells Are Activated during Hypoxia via Endoglin/Alk-1/Smad1/5 Signaling in Vivo and in Vitro
, Atherosclerosis Suppls 9(1): 4-5 (2008)

Association between Serum Gamma-Glutamyltransferase Levels and Coronary Microvascular Function
, Atherosclerosis Suppls 9(1): 6-7 (2008)

Intensive Lipid Lowering with Atorvastatin is Associated with Significant Cardiovascular Benefits in Coronary Patients with Diabetes and Chronic Kidney Disease
, Atherosclerosis Suppls 9(1): 8-9 (2008)

N-Myc Downstream-Regulated Protein 2 Modulates Pdgf-Aa Production in Macrophage Foam cells via Inhibition on Activation of Extracellular Signal-Regulated Kinase
, Atherosclerosis Suppls 9(1): 9-10 (2008)

Small Dense Ldl Cholesterol, Hdl Particles, Insulin, Adiponectin, and Glycated Albumen as Prospective Chd Risk Factors in the Framingham Study
, Atherosclerosis Suppls 9(1): 10-11 (2008)

Associations among Fatty Acids in Red Blood cells and Components of the Metabolic Syndrome
, Atherosclerosis Suppls 9(1): 11-12 (2008)

Pharcological Blockade of Ccr2 Inhibits the Development of Insulin Resistance and Hepatic Steatosis in Db/Db Mice
, Atherosclerosis Suppls 9(1): 12-13 (2008)

A New Hypothesis of Lipid Droplet Biogenesis
, Atherosclerosis Suppls 9(1): 13-14 (2008)

A Novel Role For Igf2/Igf2R Signaling In Homing Of Endothelial Progenitor Cells
, Atherosclerosis Suppls 9(1): 14-15 (2008)

Effects of Tirofiban on Angiographic Measures, St Resolution, and Clinical Outcome following the Primary Coronary Intervention in Patients with Stemi
, Atherosclerosis Suppls 9(1): 16-17 (2008)

Endothelial Nitric Oxide Synthase in Adipocytes Has an Anti-Lipolytic Action
, Atherosclerosis Suppls 9(1): 18-19 (2008)

Transport of Ghrelin and Obestatin in Plasma
, Atherosclerosis Suppls 9(1): 26-27 (2008)

Chylomicron Remnants Are increased in Cd36 Deficiency at Postprandial State
, Atherosclerosis Suppls 9(1): 27-28 (2008)

Recombinant Paf-Acetylhydrolase Enhances the Cholesterol Efflux from Macrophages induced by Reconstituted high Density Lipoprotein or Apolipoprotein A-I
, Atherosclerosis Suppls 9(1): 29-30 (2008)

Preheparin Serum Lipoprotein Lipase Mass in Metabolic Syndrome and Coronary Heart Disease: Interaction with Gender, Gene Polymorphism and Smoking
, Atherosclerosis Suppls 9(1): 30-31 (2008)

Apoe Genotype-By-Smoking Interactions and Early Atherosclerotic Lesions
, Atherosclerosis Suppls 9(1): 32-33 (2008)

Identification 0F Six Pcsk9 Snps In The Greek General Population And Greek Familial Hypercholesterolemic Patients
, Atherosclerosis Suppls 9(1): 34-35 (2008)

Human Cetp Expression Enhances the Mouse Survival Rate by Lowering the Systemic Inflammatory Response
, Atherosclerosis Suppls 9(1): 35-36 (2008)

Substantial Alterations in Lipid Metabolism Occur Early in the Development of Insulin Resistance in Mice as Revealed by Metabolic Profiling
, Atherosclerosis Suppls 9(1): 36-37 (2008)

Apoprotein A5 (Apoa5) Reduces Atherosclerosis in Mice
, Atherosclerosis Suppls 9(1): 37-38 (2008)

Differential effects of Rosiglitazone and Metformin on Postprandial Lipemia and Fatty Acid Metabolism in Hiv-Lipodystrophy
, Atherosclerosis Suppls 9(1): 39-40 (2008)

The Hdl Receptor Sr-Bi Plays an Important Role in Inflammation and Protects against Endotoxemia in Mice
, Atherosclerosis Suppls 9(1): 42-43 (2008)

Do Common Intronic Variants In Tcf7L2 Result In Differential Splicing Or Expression?
, Atherosclerosis Suppls 9(1): 43-44 (2008)

Role of Endotoxin in Systemic Inflammation and Development of Atherosclerosis
, Atherosclerosis Suppls 9(1): 46-47 (2008)

Acetylsalicylic Acid Use is Associated with increased Cytokine Expression in Atherosclerotic Carotid Plaques
, Atherosclerosis Suppls 9(1): 47-48 (2008)

Tgf-Beta1 Signaling in Human Promonocytic cells induced by 9-Oxononanoyl Cholesterol, a Major Cholesteryl Ester Oxidation Product
, Atherosclerosis Suppls 9(1): 54-55 (2008)

Uptake Of [14C]Cholesteryl Oleate And [3H]-Cholesterol Of The Nanoemulsion By Endothelial Cells In Presence Of Hdl And Ldl
, Atherosclerosis Suppls 9(1): 55-56 (2008)

Telomere Length Regulation of Vascular Smooth Muscle cells in a Balloon Injury Model: Effects of Oxidative Stress
, Atherosclerosis Suppls 9(1): 56-57 (2008)

Immune Responses against Fibronectin Modified by Reactive Aldehydes Released during Lipoprotein Oxidation Affects the Development of Atherosclerosis
, Atherosclerosis Suppls 9(1): 57-58 (2008)

The Role of Oxidative Stress on Intimal Hyperplasia: Modulation of Lox-1 Expression by Taurine
, Atherosclerosis Suppls 9(1): 58-59 (2008)

Angiogenesis in Adipogenesis
, Atherosclerosis Suppls 9(1): 60-61 (2008)

Influence of Ptca on Mobilization of Bone Marrow Derived Circulating Progenitor cells in Peripheral Blood
, Atherosclerosis Suppls 9(1): 61-62 (2008)

The Antiproliferative Mechanism of Cudraflavone B on Rat Arotic Smooth Muscle cells
, Atherosclerosis Suppls 9(1): 64-65 (2008)

Gpi-Anchored T-Cadherin is Shed from Endothelial cells and is Transferred to Lipoproteins: New Implications for Signaling Mechanisms and Clinical Practice?
, Atherosclerosis Suppls 9(1): 65-66 (2008)

Inhibitory effects of Synthetic Peptide Analogues of the Human Platelet Integrin Alphaiibeta Subunit on Rabbit Platelet Aggregation
, Atherosclerosis Suppls 9(1): 67-68 (2008)

Association of Plasma Hyaluronidase Activity with Atherosclerosis in Patients with Coronary Artery Disease
, Atherosclerosis Suppls 9(1): 68-69 (2008)

Endothelial Dysfunction Markers before and after Cpap Treatment in Patients with Obstructive Sleep Apnea Syndrome
, Atherosclerosis Suppls 9(1): 69-70 (2008)

Subclinical Atherosclerosis is increased in type 2 Diabetic Patients with Microalbuminuria Evaluated by Intima- Media Thickness and Pulse Wave Velocity
, Atherosclerosis Suppls 9(1): 71-72 (2008)

Fasting and Postprandial Apo-B48 Are increased in Patients with type 2 Diabetes with Atherosclerosis
, Atherosclerosis Suppls 9(1): 72-73 (2008)

Cardiovascular Risk in a Local Population of Diabetic Subjects
, Atherosclerosis Suppls 9(1): 73-74 (2008)

Soluble Receptor of Advanced Glycation End Products is Inversely Related to Coronary Atheromatosis in Diabetics
, Atherosclerosis Suppls 9(1): 74-75 (2008)

Mashhad Stroke Incidence Study
, Atherosclerosis Suppls 9(1): 77-78 (2008)

Association of Cystatin C with Mortality: Data from the Luric Study
, Atherosclerosis Suppls 9(1): 78-79 (2008)

Prevalance and Outcomes of Coronary Artery Anomalies in 12,457 Adult Patients Underwent Coronary Angiography
, Atherosclerosis Suppls 9(1): 79-80 (2008)

Doca-Salt Hypertensive Apo e Ko Mice; effect of high Bp on Aherosclerosis
, Atherosclerosis Suppls 9(1): 81-82 (2008)

Ldl Goals Of German Practice-Based Cardiologists For Patients With Chd/Chd Risk Equivalents And Ldl 100 Mg/Dl: Results Of The 2L-Register
, Atherosclerosis Suppls 9(1): 82-83 (2008)

A Novel Bioindexes for Evaluation of Lipid Risk Factors for Atherosclerosis in Chronically Hemodialyzed Patients
, Atherosclerosis Suppls 9(1): 83-84 (2008)

Oxidized Ldl Outperforms other Lipid Markers and is Comparable to Carotid Intima-Media Thickness in Predicting Extensive Premature Coronary Atherosclerosis
, Atherosclerosis Suppls 9(1): 84-85 (2008)

Low Hdl Cholesterol is Associated with Poor 10-Years Survival in Men but not in Women among the Elderly
, Atherosclerosis Suppls 9(1): 86-87 (2008)

Prognostic Implications of Erectile Dysfunction as Early Sign of Atherosclerosis
, Atherosclerosis Suppls 9(1): 91-92 (2008)

Glycemia Trends in School Children in Serbia
, Atherosclerosis Suppls 9(1): 95-96 (2008)

Do low Hdl Cholesterol Levels Have Role in Aspirin Resistance?
, Atherosclerosis Suppls 9(1): 96-97 (2008)

Individual Global Risk Of Polish Population And It'S Relation To Medical Care. Results Of National Multicenter Health Survey (Wobasz)
, Atherosclerosis Suppls 9(1): 97-98 (2008)

Regular Exercise Reduced Plasmatic Levels of Il-6 Inwomen with Metabolic Syndrome
, Atherosclerosis Suppls 9(1): 99-100 (2008)

Similarities Of Hepatic Lipase -514C/T And Cholesteryl Ester Transfer Protein I405V Polymorphisms In Brazilian Hyperalphalipoproteinemics
, Atherosclerosis Suppls 9(1): 106-107 (2008)

Update and Analysis of the Ucl low Density Lipoprotein Receptor Gene (Ldlr) Familial Hypercholesterolemia (Fh) Database
, Atherosclerosis Suppls 9(1): 107-108 (2008)

The Gender Limited effect Usf1 Gene Polymorphisms in the Turkish Adult Risk Factor (Tarf) Study
, Atherosclerosis Suppls 9(1): 108-109 (2008)

Variation at the Ldlr Gene is Associated with Plasma Lipid Levels and Chd in the Prosper Study
, Atherosclerosis Suppls 9(1): 109-110 (2008)

Association Of Apo A5 Variants -1131T/C And S19W With Hypertriglyceridemia In A Mediterranean Spanish Working Population
, Atherosclerosis Suppls 9(1): 111-112 (2008)

Impact of Low-Density Lipoprotein Receptor (Ldlr) Mutational Class on Carotid Atherosclerosis in Patients with Familial Hypercholesterolemia (Fh)
, Atherosclerosis Suppls 9(1): 112-113 (2008)

Impact of Apolipoprotein(A) Isoforms on Plasma Lipoprotein(A) Concentrations and their Association with Coronary Artery Disease
, Atherosclerosis Suppls 9(1): 113-114 (2008)

The Role of Plasma Levels Interleukin-6 on Mortality in Non-Obese Patients with Newly Diagnosed Heart Failure, during 12-Months of Follow-Up
, Atherosclerosis Suppls 9(1): 114-115 (2008)

B6 Vitamers as Predictors of Mortality in Stable Angina Patients
, Atherosclerosis Suppls 9(1): 115-116 (2008)

Platelet, Endothelial and Monocyte Microparticles Are Generated during Acute Myocardial Infarction and in Stable Angina
, Atherosclerosis Suppls 9(1): 117-118 (2008)

Low Titers of Human Anti-Oxldl Autoantibodies Are Associated with Unstable Coronary Disease
, Atherosclerosis Suppls 9(1): 118-119 (2008)

Association of Adiponectin with Insulin Resistance and Liver Enzymes in Dyslipidemic Subjects: Relationship to Nonalcoholic Fatty Liver Disease?
, Atherosclerosis Suppls 9(1): 119-120 (2008)

Visceral Adiposity and Insulin Resistence in Nafald-Nash Subjects: Utility of Abdominal Ultrasound
, Atherosclerosis Suppls 9(1): 120-121 (2008)

High-Density Lipoprotein Subclasses in Patients with or without the Metabolic Syndrome
, Atherosclerosis Suppls 9(1): 126-127 (2008)

Stady of Metabolic Disorders and Inflamatory Markers in Patients with Angina Pectoris and Metabolic Syndrome
, Atherosclerosis Suppls 9(1): 127-128 (2008)

Effect of Components of Metabolic Syndrome on Homeostasis of Cholesterol
, Atherosclerosis Suppls 9(1): 129-130 (2008)

Subclinical Atherosclerosis (Sa) and Metabolic Syndrome (Ms)
, Atherosclerosis Suppls 9(1): 130-131 (2008)

Would Metabolic Syndrome affect the Patterns or Causes of Restenosis after Drug-Eluting Stent Implantation? An Intravascular Ultrasound Study
, Atherosclerosis Suppls 9(1): 132-133 (2008)

Effects of Fenofibrate and Orlistat, Alone or in Combination, on Plasma Visfatin Levels in Subjects with Metabolic Syndrome
, Atherosclerosis Suppls 9(1): 133-134 (2008)

The Relationship between Estabilished Coronary Risk Factors and Serum Copper and Zinc Concentrations in a Larg Persian Population Sample
, Atherosclerosis Suppls 9(1): 136-137 (2008)

The Nutritional Benefits of Argan Oil in Obesity Risk Prevention
, Atherosclerosis Suppls 9(1): 137-138 (2008)

The Hamster as an Experimental Model to Study the effect of the Hyperlipemic Diet on the Cerebral Circulation
, Atherosclerosis Suppls 9(1): 138-139 (2008)

Effectiveness of a Food Supplement (Riducol) in Improving the Lipid Panel in Dyslipidaemic Subjects
, Atherosclerosis Suppls 9(1): 139-140 (2008)

Levels of Leptin and Soluble Leptin Receptors at Patients with a Metabolic Syndrome Depending on Carbohydrate Disoders
, Atherosclerosis Suppls 9(1): 140-141 (2008)

Maternal Obesity, Offspring Birth Weight and Offspring Blood Pressure at Age 17: The Jerusalem Perinatal Study
, Atherosclerosis Suppls 9(1): 141-142 (2008)

Low Hip Circumference and Early Cardiovascular Morbidity and Mortality among Men and Women
, Atherosclerosis Suppls 9(1): 142-143 (2008)

Identification of Proteins Secreted by Artery Biopsies in the Search for Atherothrombotic Biomarkers
, Atherosclerosis Suppls 9(1): 143-144 (2008)

Altered Fibrin Clot Properties and Cardiac Mortality in Patients on Long-Term Hemodialysis
, Atherosclerosis Suppls 9(1): 144-145 (2008)

What is the Better Predictor for Stroke at Hypertensive Patients: Intima Media Thickness or Dilatation of Carotid Arteries?
, Atherosclerosis Suppls 9(1): 146-147 (2008)

Increased Vascular Diameter and Decreased Pulse Wave Velocity in Obese Children
, Atherosclerosis Suppls 9(1): 148-149 (2008)

Relationship of Weight and Cord Blood Lipoproteins at Birth with Lipid Profile in Childhood
, Atherosclerosis Suppls 9(1): 150-151 (2008)

Association between Homocysteine and Depression: The Conselice Study of Brain Aging
, Atherosclerosis Suppls 9(1): 151-152 (2008)

Diagnosis of Familiar Combined Hyperlipidemia by small Dense Ldl-Cholesterol
, Atherosclerosis Suppls 9(1): 152-153 (2008)

Equivalence of Subclinical Atherosclerosis Measurements to Cardivascular Death for Evaluating Risk Factor Impact. The Refine Reykjavik Study
, Atherosclerosis Suppls 9(1): 153-154 (2008)

Five Year Results of the Treatment Strategy Based upon Fractional Flow Reserve Measurements in Patients with Borderline Coronary Artery Lesions
, Atherosclerosis Suppls 9(1): 156-157 (2008)

Fibrin Degradation Products in Acute Aortic Dissection
, Atherosclerosis Suppls 9(1): 157-158 (2008)

Arterial Hypertension, increased Vascular Nadph Oxidase Activity and Lipid Peroxidation in an Experimental Model of Atherogenesis
, Atherosclerosis Suppls 9(1): 158-159 (2008)

Relation between Carotid Intima Media Thickness and Extent of Coronary Artery Disease in Patients with Acute Coronary Syndrome
, Atherosclerosis Suppls 9(1): 164-165 (2008)

Des, like Bms, do not Influence Systemic Inflammatory Status Related with Inflammatory cells after Pci in Stable Angina Pectoris
, Atherosclerosis Suppls 9(1): 166-167 (2008)

Clinical Significance of the Treatment Timing of Clopidogrel in Patients Undergoing Coronary Stenting
, Atherosclerosis Suppls 9(1): 167-168 (2008)

Outcome Comparison to Take Advantage of Modified Platelets Aggregation and Pfa-100 Analysis to Rationalize Therapeutic Ldl-Apheresis Procedure
, Atherosclerosis Suppls 9(1): 168-169 (2008)

Lipid Profile And Hyperhomocyteinemia In The Active Stage Of BehEt' S Disease
, Atherosclerosis Suppls 9(1): 173-174 (2008)

Can Nt-Pro Bnp together with Doppler Tissue Imaging Predict Severity of Coronary Artery Disease in Patients with Acute Coronary Syndrome?
, Atherosclerosis Suppls 9(1): 174-175 (2008)

The Role of Lp(A) Levels and Apoprotein(A Phenotype in the Development of Atherosclerosis in Patients with Cad
, Atherosclerosis Suppls 9(1): 175-176 (2008)

Blood Lipid Levels and Waist Circumference as Cardiovascular Risk Factors, Comparation between two Definitions
, Atherosclerosis Suppls 9(1): 176-177 (2008)

In Vivo Imaging of Inflammation in the Wall of Abdominal Aortic Aneurysms
, Atherosclerosis Suppls 9(1): 178-179 (2008)

Cardiovascular Risk Factors and Carotidal Ultrasonography Evaluation in Patients with Autoimmune Diseases
, Atherosclerosis Suppls 9(1): 180-181 (2008)

The Cerebral Hemodinamic Status in Relaton to the type of Colateral Supply in Patients with Ica High-Grade Changes
, Atherosclerosis Suppls 9(1): 181-182 (2008)

Relationship between Visceral Fat Surface and Cardiovascular Complications in Transplanted Patients
, Atherosclerosis Suppls 9(1): 182-183 (2008)

Patients Attaining European Guidelines Ldl-C Goal (<2 Mmol/L) in 3 Studies Evaluating Switch to Ezetimibe/Simvastatin versus Statin Dose Doubling
, Atherosclerosis Suppls 9(1): 185-186 (2008)

Time and Dose-Related effects on the Lipid Profile in Hyperlipidemia Patients following Triple Combination Therapy with Ezetimibe/Simvastatin + Niacin
, Atherosclerosis Suppls 9(1): 186-187 (2008)

Lipid-Altering Efficacy Of Ezetimibe/Simvastatin 10/40Mg Compared To Doubling Statin Dose In Patients Admitted To The Hospital For Recent Coronary Event
, Atherosclerosis Suppls 9(1): 188-189 (2008)

Apo-Ai Lipoproteins Are increased by Ezetimibe in Patients with Refractary Familiar Hypercholesterolemia
, Atherosclerosis Suppls 9(1): 189-190 (2008)

Ace-Inhibitors and Diuretics Reduce Titers of Antibodies Anti-Oxldl in Hypertensive Patients
, Atherosclerosis Suppls 9(1): 190-191 (2008)

Rosiglitazone and Fenofibrate Improve Hdl Metabolism Assessed by Ferhdl
, Atherosclerosis Suppls 9(1): 191-192 (2008)

Safety and Efficacy of Long-Term Administration of a Fenofibrate/Pravastatin Fixed Combination in high Risk Patients with Mixed Hyperlipidemia
, Atherosclerosis Suppls 9(1): 192-193 (2008)

Safety Profile of Extended-Release Niacin/Laropiprant in Patients with Dyslipidemia
, Atherosclerosis Suppls 9(1): 194-195 (2008)

Safety of Lipid-Lowering Treatment
, Atherosclerosis Suppls 9(1): 195-196 (2008)

Korean Rosuvastatin Effectiveness Study in Nondiabetic Metabolic Syndrome (Krest)
, Atherosclerosis Suppls 9(1): 196-197 (2008)

Atorvastatin Inhibit Intimal Hyperplasia and Oxidative Stress of Rabbit Carotid Artery induced by Vascular Adventitial Injury
, Atherosclerosis Suppls 9(1): 197-198 (2008)

Effects of Atorvastatin and Co in the Pathogenesis of Intimal Hyperplasia following Vascular Injury in Healthy and Hypercholesterolemic Pigs
, Atherosclerosis Suppls 9(1): 198-199 (2008)

Efficacy of Rosuvastatin 10 Mg versus Atorvastatin 20 Mg in Patients with Diabetes: Subgroup Results from the Pulsar Study
, Atherosclerosis Suppls 9(1): 199-200 (2008)

High-Dose Atorvastatin Attenuates Cardiovascular Risk Prediction of the Metabolic Syndrome Components: The Treating to New Targets Study
, Atherosclerosis Suppls 9(1): 201-202 (2008)

Comparative Effectiveness of Atorvastatin, Simvastatin, Lovastatin and Fluvastatin on Pulse Wave Velocity at Patients with Dislipidemia and high Cardiovascular Risk
, Atherosclerosis Suppls 9(1): 202-203 (2008)

Effects of Atorvastatin on Red Blood cell Na+/Li- Countetransport in Hyperlipidemic Patients with and without Hypertension
, Atherosclerosis Suppls 9(1): 204-205 (2008)

Ldl Cholesterol Goal Attainments in the Ideal Study
, Atherosclerosis Suppls 9(1): 205-206 (2008)

Marcador-2.Antiinflammatory and Antiatherothrombotic effects of a Combination of Manidipine + Lisinopril in Hypertensive Non-Diabetic Patients with Metabolic Syndrome
, Atherosclerosis Suppls 9(1): 210-211 (2008)

Baseline Data of Jppp (The Large Randomized Controlled Trial of Primary Prevention by Enteric Coated Low-Dose Aspirin in Japan)
, Atherosclerosis Suppls 9(1): 213-214 (2008)

The effect of Tirofiban on Qt Dispersion in Acute Coronary Syndromes
, Atherosclerosis Suppls 9(1): 218-219 (2008)

Lipidscreening in Families of Patients at high Risk for Cardiovascular Disease
, Atherosclerosis Suppls 9(1): 219-220 (2008)

Gamma-Glutamyltransferase Deposits in Human Atherosclerotic Plaques: Potential Relationships with the Circulating Enzyme
, Atherosclerosis Suppls 9(1): 220-221 (2008)

The Effectiveness of Rosuvastatin in high Risk Patients Treatment
, Atherosclerosis Suppls 9(1): 221-222 (2008)

The Role of Endothelial cell in the Immune Inflamation Initiation during the Atherosclerosis
, Atherosclerosis Suppls 9(1): 224-225 (2008)

Is There Any relation between Coronary Atherosclerosis and Tympanosclerosis?
, Atherosclerosis Suppls 9(1): 225-226 (2008)

Oronary Artery Endarterectomy in Patients with Long Segment In-Stent Restenosis
, Atherosclerosis Suppls 9(1): 226-227 (2008)

Serum Lipoprotein(A) and Homocysteine Levels Related to five Risk Scores for Coronary Artery Disease
, Atherosclerosis Suppls 9(1): 229-230 (2008)

Estimation of Cardiovascular Complications in Subjects with Metabolic Syndrome and high Cardiovascular Risk
, Atherosclerosis Suppls 9(1): 231-232 (2008)

Atorvastatin effects on Inflammation and Platelet Activation Markers following Drug Eluting Stenting in Patients with Stable Coronary Artery Disease
, Atherosclerosis Suppls 9(1): 233-234 (2008)

A Comparison of Parathormone, Ferritin and Echocardiographic Parameters in Differnet Body Mass Index Levels in Patients with Hemodialysis
, Atherosclerosis Suppls 9(1): 235-236 (2008)

Coagulation Markers:D-Dimers And Fibrinogen During Acute Infection Predict Cardiovascular Events
, Atherosclerosis Suppls 9(1): 236-237 (2008)

Lipidaemic Profile And Heart Rate Variability (Hrv) In Chronic Kidney Disease (Ckd) Patients With Or Without Type2 Diabetes Mellitus (T2Dm)
, Atherosclerosis Suppls 9(1): 237-238 (2008)

Polymorphism of Angiotensinogen Gene and the Risk of Coronary Heart Disease in type 2 Diabetic Patients
, Atherosclerosis Suppls 9(1): 238-239 (2008)

The effect of Epo Treatment on Insulin Resistance and Inflammatory Markers in Patients on Maintenance Hemodialysis
, Atherosclerosis Suppls 9(1): 239-240 (2008)

Significance of small Dense Low-Density Lipoproteins in Coronary Heart Disease
, Atherosclerosis Suppls 9(1): 242-243 (2008)

The Influence of Oxidative Parameters, Prolidase, Paraoxonase and Arylesterase Activities on mean Blood Pressure
, Atherosclerosis Suppls 9(1): 244-245 (2008)

Endothelial Dysfunction and low Grade Chronic Inflamation in Subclinical Hypothyroidism
, Atherosclerosis Suppls 9(1): 246-247 (2008)

Angiogenin, a Marker of Angiogenesis Increases with Coronary Heart Disease Severity
, Atherosclerosis Suppls 9(1): 247-248 (2008)

Interrelation of Insulin-Resistance and over Body Weight in Males and Females with Ischemic Heart Disease
, Atherosclerosis Suppls 9(1): 248-249 (2008)

Anti-Oxidized Ldl Autoantibodies in Diabetic Persons Undergoing Percutaneous Coronary Revascularization
, Atherosclerosis Suppls 9(1): 249-250 (2008)

Presence of Anti-Oxidized Ldl Antibodies in Morbidly Obese Persons and their Evolution following Bariatric Surgery
, Atherosclerosis Suppls 9(1): 250-251 (2008)

Anti-Atherogenic effects of a 1-Yr Intervention Program in 50-65 Yrs-Old Overweight Women
, Atherosclerosis Suppls 9(1): 252-253 (2008)

Association of Helicobacter Pylori Seropositivity with Coronary Artery Disease
, Atherosclerosis Suppls 9(1): 253-254 (2008)

The Early Impact of Cardiac and Renal Influence before Exercise Intolerance in Middle-Aged Females
, Atherosclerosis Suppls 9(1): 254-255 (2008)

Prevention on Sudden Cardiac Death in Patients with Acute Coronary Syndrom: Effect of Highly Purified Omega 3 Fatty Acid
, Atherosclerosis Suppls 9(1): 256-257 (2008)

Effect of Moxonidine on some Inflammatory Markers and T cell Repertoire in Essential Hypertension
, Atherosclerosis Suppls 9(1): 259-260 (2008)

Association between Plasma Levels of C-Reactive Protein and Numbers of Children
, Atherosclerosis Suppls 9(1): 261-262 (2008)

Continental versus Mediterranean Differences in Risk Factors in Croatian Ischemic Heart Disease Patients - Taspic-Cro V Study
, Atherosclerosis Suppls 9(1): 262-263 (2008)

Antioxidative Stress Systems in Subjects with Familial Hypercholesterolemia
, Atherosclerosis Suppls 9(1): 265-266 (2008)

Influence of Lipoprotein(A) on Restenosis after Percutaneous Transluminal Angioplasty (Pta) in Patients with Peripheral Arterial Occlusive Disease (Pad)
, Atherosclerosis Suppls 9(1): 267-268 (2008)

Abstract: 26 High-Dose Atorvastatin Provides Sustained Benefit in Reducing Risk of Cv Disease among Stable Chd Patients 65 Years
, Atherosclerosis Suppls 10(2): e83-e84 (2009)

Abstract: 31 Ezetimibe/Simvastatin (E/S) Vs Atorvastatin (A) in Metabolic Syndrome (Ms) Patients with Hypercholesterolemia (Hc)
, Atherosclerosis Suppls 10(2): e89-e90 (2009)

Abstract: 65 Cholesterol-Lowering Therapy with the Cholesterol Absorption Inhibitor Ezetimibe Inhibits Plaque Destabilization and Rupture in the Brachiocephalic Arteries of Apoe-Deficient Mice
, Atherosclerosis Suppls 10(2): e212-e213 (2009)

Abstract: 508 Comprehensive Cardiac Rehabilitation Program Strongly Prevents New Onset of Myocardial Ischemia in Patients Received Percutaneous Coronary Intervention
, Atherosclerosis Suppls 10(2): e254-e255 (2009)

Abstract: 510 Impact of Smoking and High-Density Lipoproteins on Coronary Plaque Regression during Statin Therapy in Acute Coronary Syndrome; Sub-Analysis of Japan-Acs
, Atherosclerosis Suppls 10(2): e257-e258 (2009)

Abstract: 517 Efficacy and Safety of Fenofibric Acid in Combination with Atorvastatin and Ezetimibe in Patients with Mixed Dyslipidemia: A Phase 3 Study
, Atherosclerosis Suppls 10(2): e262-e263 (2009)

Abstract: P1208 Relationship between Glycated Hemoglobin, Blood Pressure and Carotid Artery Atherosclerosis in Nondiabetic Patients
, Atherosclerosis Suppls 10(2): e315-e316 (2009)

Abstract: 573 Correlation of Non-Hdl-C and Ldl-C with Apob during Lipid-Lowering Therapy in Patients with Combined Hyperlipidemia (Hl)
, Atherosclerosis Suppls 10(2): e333-e334 (2009)

Abstract: 581 Cholesterol Balance in the Presence of Inhibition of Intestinal Absorption and Endogenous Production by Ezetimibe And/Or Simvastatin in Men
, Atherosclerosis Suppls 10(2): e340-e341 (2009)

Abstract: 582 Attainment of Single/Dual Treatment Levels for Ldl-C and Non-Hdl-C, Apob, or Hs-Crp in Patients with Metabolic Syndrome (Ms): Ezetimibe(E)/Simvastatin(S) Vs Atorvastatin(A)
, Atherosclerosis Suppls 10(2): e342-e343 (2009)

Abstract: 609 Timing for Adequate Imaging the Vulnerable Aortic Lesions with Biofunctionalized Magnetic Nanoparticles
, Atherosclerosis Suppls 10(2): e360-e361 (2009)

Abstract: 610 Segment-Specific Response to Atherosclerosis within the Carotid Arteries Detected using Magnetic Resonance Imaging (Mri)
, Atherosclerosis Suppls 10(2): e362-e363 (2009)

Abstract: 1006 Ezetimibe/Simvatastatin (E/S) plus Extended Release Niacin (N) in Hyperlipidemia (Hl) Patients with Diabetes (Dm) or Metabolic Syndrome (Ms)
, Atherosclerosis Suppls 10(2): e379-e380 (2009)

Abstract: 1007 New Onset Diabetes Mellitus (Dm) in Patients with Hyperlipidemia (Hl) Taking Ezetimibe/Simvastatin (E/S) +/ Niacin (N)
, Atherosclerosis Suppls 10(2): e381-e382 (2009)

Abstract: 1071 Plasma Pentraxin 3 Levels Reflect Metabolic Syndrome in Patients with Coronary Artery Disease
, Atherosclerosis Suppls 10(2): e420-e421 (2009)

Abstract: P156 Cholesterol Lowering Inhibits Crystal Formation with Associated Plaque Disruption, Thrombosis and Inflammation
, Atherosclerosis Suppls 10(2): e472-e473 (2009)

Abstract: P182 Pitavastatin Incorporated Nanoparticle-Eluting Stent Attenuates In-Stent Stenosis, and Prevents Adverse effects of Silorimus-Eluting Cypher Stent in Porcine Coronary Artery Model
, Atherosclerosis Suppls 10(2): e499-e500 (2009)

Abstract: P184 small Arteries and Renal Medulla Are Major Targets of Antioxidant Enzyme Dysfunction in a Model of Atherogenesis
, Atherosclerosis Suppls 10(2): e502-e503 (2009)

Abstract: P285 Identification of Extremely High-Risk Plaques on the Basis of low Endothelial Shear Stress: Implications for Risk Stratification
, Atherosclerosis Suppls 10(2): e592-e593 (2009)

Abstract: P301 Association of Cigarette Smoking with Early Onset of Acute Coronary Syndrome and Lipid Disorder; Subanalysis of Japan-Acs
, Atherosclerosis Suppls 10(2): e609-e610 (2009)

Abstract: P359 the Impact of Diabetes on Major Cardiovascular Events in Patients with Familial Combined Hyperlipoproteinemia
, Atherosclerosis Suppls 10(2): e668-e669 (2009)

Abstract: P453 N-3 Polyunsaturated Fatty Acid Decrease Homocysteine via Regulating Mrna Expression of the Enzymes in Methionine Metabolsim in Hepg2
, Atherosclerosis Suppls 10(2): e763-e764 (2009)

Abstract: P485 Alkaloids Extracted from Lobelia Chinensis Lour Inhibited the Formation of Atherosclerosis Independent of Lipid Reduction and Apoe Presence
, Atherosclerosis Suppls 10(2): e797-e798 (2009)

Abstract: P764 the effects of Extended Release Niacin in Combination with Omega 3 Fatty Acid Supplements in the Treatment of Elevated Lipoprotein(A)
, Atherosclerosis Suppls 10(2): e938-e939 (2009)

Abstract: P773 Efficacy of Ezetimibe Added to Atorvastatin Vs Uptitration of Atorvastatin in the Elderly
, Atherosclerosis Suppls 10(2): e948-e949 (2009)

Abstract: P787 Resting Heart Rate Remains an Independent Risk Factor for Mortality in Healthy Subjects after Adjusting for Inflammatory Markers, the Copenhagen City Heart Study (Cchs)
, Atherosclerosis Suppls 10(2): e963-e964 (2009)

Abstract: P790 a New Approach to Classifying Chd in Normolipodemic Individuals using high Performance Lipoprotein Density Profiling
, Atherosclerosis Suppls 10(2): e967-e968 (2009)

Abstract: P864 Genetic Analysis of Variants on Genes Influencing Inflammation and Insulin Resistance: Effect on Coronary Artery Disease
, Atherosclerosis Suppls 10(2): e1008-e1009 (2009)

Abstract: P903 Carotid Lumen and Vessel Diameters and their Relationships with Carotid Intima-Media Thickness (Imt) in four Ethnic Groups: The Multi-Ethnic Study of Atherosclerosis
, Atherosclerosis Suppls 10(2): e1048-e1049 (2009)

Abstract: P947 Ezetimibe/Simvastatin (E/S) and Atorvastatin (A) Treatment Modify Apob, Ldl-C, and Non-Hdl-C Correlations in Metabolic Syndrome (Ms) Patients at Moderately high Risk(Mhr)/High Risk(Hr) for Chd
, Atherosclerosis Suppls 10(2): e1094-e1095 (2009)

Abstract: P948 Ezetimibe(E)+Atorvastatin(A) Vs. A Up-Titration In Moderately High Chd Risk (Mhr) Or High Chd Risk (Hr) Patients: Effects Of Baseline Body Mass Index (Bmi), Fasting Blood Sugar (Fbs) And Hs-Crp
, Atherosclerosis Suppls 10(2): e1096-e1097 (2009)

Abstract: P949 Influence of Age, Gender, and Race on the Efficacy of Ezetimibe plus Atorvastatin Vs. Atorvastatin Uptitration in Moderately High/High Chd Risk Patients
, Atherosclerosis Suppls 10(2): e1098-e1099 (2009)

Abstract: P964 Impact of Statin Dose on Lipid Levels in Patients with Atherosclerotic Disease: Results from the Voyager Individual Patient Data Meta-Analysis
, Atherosclerosis Suppls 10(2): e1114-e1115 (2009)

Abstract: P965 Statin Dose effects on Lipid Levels in Patients with Diabetes Mellitus: Observations from the Voyager Individual Patient Data (Ipd) Meta-Analysis
, Atherosclerosis Suppls 10(2): e1116-e1117 (2009)

Abstract: P966 effect of Age/Gender/Race on Ezetimibe/Simvastatin Vs. Atorvastatin Efficacy in Metabolic Syndrome Patients with Moderately High/High Chd Risk
, Atherosclerosis Suppls 10(2): e1118-e1119 (2009)

Abstract: P967 Influence of Metabolic Syndrome (Ms) Factors and Insulin Resistance (Ir) on Ezetimibe (E)/Simvastatin (S) and Atorvastatin (A) Efficacy in Patients with Ms and Moderately high (Mh) or high (H) Chd Risk
, Atherosclerosis Suppls 10(2): e1120-e1121 (2009)

Abstract: P1166 Red Wine Increases the Number and Functions of Circulating Endothelial Progenitor cells
, Atherosclerosis Suppls 10(2): e1192-e1193 (2009)

Abstract: P1167 C-Reactive Protein Predicts Functional Status and Correlates with left Ventricle Ejection Fraction in Patients with Chronic Stable Angina
, Atherosclerosis Suppls 10(2): e1194-e1195 (2009)

Abstract: P823 Ezetimibe (E) Added to Atorvastatin (A): Effect on Lipoprotein Subclass Cholesterol Content in Patients with Higher versus Lower Triglyceride Levels (Tg)
, Atherosclerosis Suppls 10(2): e1212-e1213 (2009)

Abstract: P1175 Relationship between Weight and Cardiovascular Risk Factors
, Atherosclerosis Suppls 10(2): e1238-e1239 (2009)

Abstract: P1214 Microparticles before and after Angioplasty of Iliac Artery Stenosis
, Atherosclerosis Suppls 10(2): e1268-e1269 (2009)

Abstract: P1308 Ezetimibe/Simvastatin (E/S) Vs Atorvastatin (A) in Patients with Hypercholesterolemia (Hc) and Metabolic Syndrome (Mets) Grouped by Presence of Atherosclerotic Vascular Disease (Avd)
, Atherosclerosis Suppls 10(2): e1364-e1365 (2009)

Abstract: P1318 Lipid Ratios and Risk for Metabolic Syndrome
, Atherosclerosis Suppls 10(2): e1375-e1376 (2009)

Abstract: P1372 Mutations in Hfe Causing Hemochromatosis Are Associated with Primary Hypertriglyceridemia
, Atherosclerosis Suppls 10(2): e1421-e1422 (2009)

Abstract: P1443 Long-Term Effect Of Combination Ezetimibe/Simvastatin + Extended-Release Niacin (E/S+N) On Lipoprotein Subclasses In Patients With Hyperlipidemia (Hl)
, Atherosclerosis Suppls 10(2): e1493-e1494 (2009)

Abstract: S2-12 Visualising Inflamed Endothelial Cells: Molecular Imaging using Mri and Targeted Uspios
, Atherosclerosis Suppls 10(2): e1510-e1511 (2009)

Abstract: S2-15 Differential Atherogenic effect of low Endothelial Shear Stress in Plaque-Free Vs. Atherosclerotic Coronary Segments: A Serial Ivus Study
, Atherosclerosis Suppls 10(2): e1514-e1515 (2009)

Abstract: S2-21 Calcification in an Atherosclerotic Plaque: Ultrastructural Insights
, Atherosclerosis Suppls 10(2): e1521-e1523 (2009)

Abstract: S3-29 Multiple Mutations Perturb a small Number of Pathways in an Hdl Mutagenesis Screen
, Atherosclerosis Suppls 10(2): e1541-e1542 (2009)

Abstract: 1051 Ongoing Clinical Trials of the Statin/Ezetimibe Combination
, Atherosclerosis Suppls 10(2): e1620-e1621 (2009)

Abstract: 559 Chemokines as Therapeutic Targets in Atherosclerosis
, Atherosclerosis Suppls 10(2): e1627-e1628 (2009)

Abstract: 22 Efficacy of Statins
, Atherosclerosis Suppls 10(2): e1646-e1648 (2009)

W24 Carotid Intima-Media Thickness is not Independently Predictive for Hard Coronary Events in Men and Women the Heinz Nixdorf Recall Study
, Atherosclerosis Suppls 11(2): 5-6 (2010)

W33 Changes of Proinflammatory Cytokines, Chemoattractants and Destructive Metalloproteinases Contents during Unstable Atherosclerotic Plaque Formation
, Atherosclerosis Suppls 11(2): 7-8 (2010)

W38 Genetic Variation in Liver X Receptor Alpha and Risk of Ischemic Vascular Disease in the General Population
, Atherosclerosis Suppls 11(2): 8-9 (2010)

W43 Genetic Deficiency in Functional Mmp-10 Reduces Progression of Atherosclerosis in Apolipoprotein E-Knockout Mice
, Atherosclerosis Suppls 11(2): 9-10 (2010)

W52 Protection against Atherosclerosis in Cav-1 is Due to Cav-1/ in Non-Hematopoietic cells
, Atherosclerosis Suppls 11(2): 11-12 (2010)

L2 Visualising Inflamed Atherosclerotic Plaques: Molecular Imaging using Mri and Targeted Ultrasmall Superparamagnetic Particles of Iron Oxide (Uspio)
, Atherosclerosis Suppls 11(2): 13-14 (2010)

P19 Orphan Nuclear Receptor Nur77 Suppresses Inflammatory Response Partially Dependent on Cox-2 in Macrophages induced by Oxidized Low-Density Lipoprotein
, Atherosclerosis Suppls 11(2): 20-21 (2010)

P24 effect of Telmisartan on the Arteriovenous Index in Retinal Microvascularization
, Atherosclerosis Suppls 11(2): 21-22 (2010)

P29 the Role of Exercise and Endocannabinoid System in Atherosclerotic Plaque Stability Experimental Study
, Atherosclerosis Suppls 11(2): 22-23 (2010)

P33 a Nutrigenomic Approach to Study the effect of Herbal Polyphenols on Atherogenic Transcriptome
, Atherosclerosis Suppls 11(2): 23-24 (2010)

P38 Generation of Recombinant Antibodies to Nitrotyrosine to Facilitate the Identification of Novel Protein Biomarkers of Atherosclerosis
, Atherosclerosis Suppls 11(2): 24-25 (2010)

P43 N-Terminal Pro-Brain Natriuretic Peptide but not High-Sensitivity C-Reactive Protein is Related to Severity of Coronary Stenosis in Acute Coronary Syndrome
, Atherosclerosis Suppls 11(2): 25-26 (2010)

P48 Oxldl/beta2Gpi Complex As An Early Marker Of Atherosclerosis Initiation In Healthy Middle-Aged Men With Abdominal Obesity
, Atherosclerosis Suppls 11(2): 26-27 (2010)

P53 Cardioprotective effect of Red Wine
, Atherosclerosis Suppls 11(2): 27-28 (2010)

P68 Simvastatin Retards Progression of Aortic Valve Stenosis in the Elderly Patients with Chronic Heart Failure and Preserved Systolic Function
, Atherosclerosis Suppls 11(2): 30-31 (2010)

P73 Relationship between Lipoprotein-Associated Phospholipase A2 and Inflammation in Coronary Heart Diseases
, Atherosclerosis Suppls 11(2): 31-32 (2010)

P78 Metabolic Syndrome and Subclinical Atherosclerosis in Young Adults
, Atherosclerosis Suppls 11(2): 32-33 (2010)

P83 Ldl-Cholesterol and Cardiovascular Events in Patients with Diabetes Mellitus type 2
, Atherosclerosis Suppls 11(2): 33-34 (2010)

P87 Carotid Atherosclerosis Associated with Late-Onset Depressive Disorders: Results from a Large Cohort Study
, Atherosclerosis Suppls 11(2): 34-35 (2010)

P92 Endothelial Function Assessed by Peripheral Artery Tonometry is a Determinant of Carotid Intimae-Media Thickness Regardless of Framingham Risk Score
, Atherosclerosis Suppls 11(2): 35-36 (2010)

P97 increased Erythrocyte Aggregability in Patients with Slow Coronary Flow
, Atherosclerosis Suppls 11(2): 36-37 (2010)

P102 Genetic Variation at the Cd36 Locus and Risk of Coronary Heart Disease in Women and Men
, Atherosclerosis Suppls 11(2): 37-38 (2010)

P107 Tnf-M-Ras-Lfa-1 Pathway Analysis in Genome-Wide Snp Data on Patients with Myocardial Infarction
, Atherosclerosis Suppls 11(2): 38-39 (2010)

P116 First Application of Risk Advancement Periods to Lipid Ratios
, Atherosclerosis Suppls 11(2): 40-41 (2010)

P121 The Protective Role Of Specific Protein-1 Against Benzo(A)Pyrene-Induced Atherogenesis
, Atherosclerosis Suppls 11(2): 41-42 (2010)

P130 Postprandial Beta cell Responsiveness does it Have a Protective Role in the Development of Diabetic Complication?
, Atherosclerosis Suppls 11(2): 43-44 (2010)

P139 the Association of Albuminuria with Angiographically determined Coronary Atherosclerosis
, Atherosclerosis Suppls 11(2): 45-46 (2010)

P144 Apolipoprotein e Genotype, Cardiovascular Biomarkers and Stroke Risk: Systematic Review of 10,550 Stroke Cases and Pooled Analysis of 74,052 Individuals
, Atherosclerosis Suppls 11(2): 46-47 (2010)

P149 does Insulin Resistance Influence Endothelial Progenitor cells in Obese Patients?
, Atherosclerosis Suppls 11(2): 47-48 (2010)

P155 effects of Ramadan Fasting on Cardiovascular Risk Factors
, Atherosclerosis Suppls 11(2): 48-49 (2010)

P160 the Prevelance of Subclinical Hypothyroidism among Patients with Acute Myocardial Infarction
, Atherosclerosis Suppls 11(2): 49-50 (2010)

P165 Asymmetric Dimethylarginine (Adma) Predicts Skin Blood Flow during Hemodialysis (Hd)
, Atherosclerosis Suppls 11(2): 50-51 (2010)

P170 Comparative Mapping of Linkage and Association Signals in Myocardial Infarction
, Atherosclerosis Suppls 11(2): 51-52 (2010)

P174 Adma (Asymmetric Dimethylarginine) Predicts All-Cause Mortality and Cardiovascular Events in Patients with Peripheral Arterial Disease: The Getabi Study
, Atherosclerosis Suppls 11(2): 52-53 (2010)

P188 Association between Atherosclerosis and Lung Function Results from International Twin Study 2009
, Atherosclerosis Suppls 11(2): 55-56 (2010)

P193 Smoking Behaviors after Acute Coronary Syndromes (Acs) in Adult Male Smokers
, Atherosclerosis Suppls 11(2): 56-57 (2010)

P198 the Association between Variation in Negr1 Gene and Body-Weight is Modulated by Physical Activity in a high Risk Mediterranean Population
, Atherosclerosis Suppls 11(2): 57-58 (2010)

P202 Persistent Lipid Abnormalities in Statin Treated Patients in Spain. The Dyslipidemia International Survey Study (Dysis-Spain)
, Atherosclerosis Suppls 11(2): 58-59 (2010)

P217 Mouse Gene Expression Networks Indicate Mitochondrial Dysfunction Causes Metabolic Inflammation in Obesity: Validation by Human Gene Expression and Snp Analysis
, Atherosclerosis Suppls 11(2): 61-62 (2010)

P222 Composite Deficiency of the Lipolytic Complex in Pregnancy-Induced Major Hypertriglyceridemia
, Atherosclerosis Suppls 11(2): 62-63 (2010)

P227 Non-Cholesterol Sterols in Common Hypercholesterolemia and Familial Combined Hyperlipemia
, Atherosclerosis Suppls 11(2): 63-64 (2010)

P232 Ldl Receptor Related Protein 1 (Lrp1) is Necessary for Apolipoprotein A5 (Apoa5) Mediated Triglyceride Reduction
, Atherosclerosis Suppls 11(2): 64-65 (2010)

P237 Hypercholesterolemia (Hc) Abrogates the Biphasic effect of Angiotensin Ii (Ang Ii) on Endogenous Cholesterol Synthesis in Human Monocytes
, Atherosclerosis Suppls 11(2): 65-66 (2010)

P242 increased Plasma Resistin Concentrations Are Associated with Atherogenic Small, Dense Low-Density Lipoproteins in Patients with Type-2 Diabetes
, Atherosclerosis Suppls 11(2): 66-67 (2010)

P251 Ezetimibe with or without Simvastatin Increases small Dense Low-Density Lipoproteins in Healthy Men a Randomized Trial
, Atherosclerosis Suppls 11(2): 68-69 (2010)

P254 Inverse Relationship between Hdl-C Raising and Hscrp Reduction in Older Patients Treated with Lipid-Lowering Therapy in the Vyteld Study
, Atherosclerosis Suppls 11(2): 69-70 (2010)

P258 the effects of Omega-3-Polyunsaturated Fatty Acids and Atorvastatin on Fatty Acid Status of Blood in Patients with Dyslipidemia
, Atherosclerosis Suppls 11(2): 70-71 (2010)

P268 the beyond Cholesterol-Lowering Activity of Pravastatin. Analysis of three Overlapping Dose Groups
, Atherosclerosis Suppls 11(2): 72-73 (2010)

P291 Simultaneous Determination of Triglyceride and Glucose Tolerance by a Novel Sequential test Protocol in 511 Patients with Coronary Artery Disease
, Atherosclerosis Suppls 11(2): 78-79 (2010)

P296 effects of Fenofibric Acid in Combination with Statin Therapy on Low-Density Lipoprotein Particle Size in Patients with Mixed Dyslipidemia
, Atherosclerosis Suppls 11(2): 79-80 (2010)

P300 effect of Probucol on an Antioxidant Property of Hdl in Patients with Heterozygous Familial Hypercholesterolemia
, Atherosclerosis Suppls 11(2): 80-81 (2010)

P309 Hdl-C Relates to Markers of Absorption but not of Synthesis of Cholesterol: Study in Subjects with low Vs. High Hdl-C
, Atherosclerosis Suppls 11(2): 82-83 (2010)

P314 Identification and Cloning of Novel Soluble and Membrane Bound Forms of Human Atp-Binding Cassette Transporter G4
, Atherosclerosis Suppls 11(2): 83-84 (2010)

P319 Resequencing the Lpl Gene in Patients with Various Hypertriglyceridemias to Determine the Relative Importance of Rare Alleles and Common Variants
, Atherosclerosis Suppls 11(2): 84-85 (2010)

P324 Perturbed Cellular Lrp1 Localization Leads to increased Hepatic Ldlr Expression with Atheroprotective Consequences
, Atherosclerosis Suppls 11(2): 85-86 (2010)

P334 HIV Infection Induces Major Changes in Hdl Particle Size Distribution and Composition: The effect of Antiretroviral Treatment and Disease Severity
, Atherosclerosis Suppls 11(2): 87-88 (2010)

P339 Usefulness Of Intima Media Thickness, apoB And Non-Hdl-C In Primary Dislipidemic Children
, Atherosclerosis Suppls 11(2): 88-89 (2010)

P348 Molecular Diagnosis of Familial Hypercholesterolemia (Fh) in Greece. Known and Novel Mutations in the low Density Lipoprotein Receptor (Ldlr) Gene
, Atherosclerosis Suppls 11(2): 90-91 (2010)

P353 Specific Oxidation of Apolipoprotein-B-100 by Myeloperoxidase
, Atherosclerosis Suppls 11(2): 91-92 (2010)

P362 Hypoxia Up-Regulates Fibulin-5 in Endothelial cells through a Hif-1 Dependent Mechanism
, Atherosclerosis Suppls 11(2): 93-94 (2010)

P367 Ldl Increases Vascular Etb2 Receptor Expression via Activation of Erk1/2 and P38 Mapk Pathways
, Atherosclerosis Suppls 11(2): 94-95 (2010)

P377 Role of Growth-Differentiation Factor 15 (Gdf-15) in a Mouse-Model of Atherosclerosis
, Atherosclerosis Suppls 11(2): 96-97 (2010)

P382 the Impact of Cigarette Smoke on the Adhesion Properties of Human Monocytes to Endothelial cells in Vitro
, Atherosclerosis Suppls 11(2): 97-98 (2010)

P387 Monocyte Chemoattractant Protein-1 (Mcp-1) is a Biological Marker for Vascular Inflammation induced by Environmental Toxicants
, Atherosclerosis Suppls 11(2): 98-99 (2010)

P392 Interaction of Platelet-Derived Microparticles with Plasma Lipoproteins. Effect on Platelet Activation
, Atherosclerosis Suppls 11(2): 99-100 (2010)

P397 Neutrophil Il-1R And Chemokine Expression Following In Vivo Extravasation In Patients With Coronary Artery Disease
, Atherosclerosis Suppls 11(2): 100-101 (2010)

P402 The Cx3C Chemokine Fractalkine And Gpib Mediate Platelet Translocation On Von Willebrand Factor Under Physiologic Flow Conditions
, Atherosclerosis Suppls 11(2): 101-102 (2010)

P411 Genomic Differences between Mouse Foamy and Non-Foamy Macrophages
, Atherosclerosis Suppls 11(2): 103-104 (2010)

P416 Inflammatory Markers in Patients Undergoing Implantable Cardioverter Defibrillator Implantation for Life Threatening Ventricular Arrhythmias
, Atherosclerosis Suppls 11(2): 104-105 (2010)

P421 Early effects of Atorvastatin and Clopidogrel Alone or Combined on Endothelial Progenitor cells and Microparticles in Subjects with Coronary Disease
, Atherosclerosis Suppls 11(2): 105-106 (2010)

P431 Mipomersen, An apo B Synthesis Inhibitor, Preferentially Reduces Small Ldl Particle Number And Increases Ldl Particle Size In HoFh Patients
, Atherosclerosis Suppls 11(2): 107-108 (2010)

Ms4 Chronic Inflammatory State Present in Familial Hypercholesterolemia is Reduced after a Fat Overload Rich in Unsaturated Fatty Acids
, Atherosclerosis Suppls 11(2): 109-110 (2010)

Ms9 Effectiveness of Omacor Monotherapy in Severe Hypertriglyceridemia
, Atherosclerosis Suppls 11(2): 110-111 (2010)

Ms14 Sex Differences In Effects Of Npc1L1 Gene Polymorphism On Cholesterol Absorption
, Atherosclerosis Suppls 11(2): 111-112 (2010)

Ms17 the Role of Acylation Stimulating Protein in Genesis of Dyslipidemias and in Regulation of Triacylglycerol Synthesis: Clinical and Experimental Data
, Atherosclerosis Suppls 11(2): 112-113 (2010)

Ms26 Cholesteryl Ester Storage Disease (Acid Lipase Deficiency): Another Factor for Early Atherosclerosis Disease. Experience from the Greek Population
, Atherosclerosis Suppls 11(2): 114-115 (2010)

Ms31 Circulating Oxidized Low-Density Lipoprotein Levels may Serve as a Risk Marker for Carotid Stenosis during Statin Therapy
, Atherosclerosis Suppls 11(2): 115-116 (2010)

Ms45 Impact of Switching to Simvastatin on low Density Lipoprotein Cholesterol Goal Attainment
, Atherosclerosis Suppls 11(2): 118-119 (2010)

Ms48 effects of Age and Statin Dose on Lipid Levels: Results from the Voyager Individual Patient Data Meta-Analysis
, Atherosclerosis Suppls 11(2): 119-120 (2010)

Ms53 low Hdl-High Inflammatory Markers in Heart Failure induced by high Frequency Pacing in Minipigs
, Atherosclerosis Suppls 11(2): 120-121 (2010)

Ms68 Atherogenic Dislipidemia in Metabolic Syndrome: Role of Insulin Resistance, Nonesterified Fatty Acids and Adipokines
, Atherosclerosis Suppls 11(2): 123-124 (2010)

Ms73 Decrease Of Plasma Levels Of Lipoprotein A [Lp(a)] After Administration Of L-Carnitine
, Atherosclerosis Suppls 11(2): 124-125 (2010)

Ms79 Molecular Study of Lpl, Apoaiv, Apoav, Apocii and Apociii Genes in Patients with Hypertriglyceridemia
, Atherosclerosis Suppls 11(2): 125-126 (2010)

Ms90 Adipocyte Factors, hsCrp And Malondialdehyde Levels In Overweight Postmenopausal Women With Normal And Impaired Ogtt
, Atherosclerosis Suppls 11(2): 127-128 (2010)

Ms97 The Effect Of The n-3/n-6 Pufa Ratio On The Transformation Of Postprandial State Proatherogenic Ldl Phenotype And Oxidative Stress Parameters
, Atherosclerosis Suppls 11(2): 129-130 (2010)

Ms130 Expression Pattern of Long Pentraxin 3 (Ptx3) in Human Atherosclerosis
, Atherosclerosis Suppls 11(2): 135-136 (2010)

Ms135 Adipophilin low Expression Reduce Cellular Lipid
, Atherosclerosis Suppls 11(2): 136-137 (2010)

Ms145 a Novel Rat Experimental Model Confirms the Critical Role of Metalloproteinases-2 and -9 in the Development of Abdominal Aneurysms
, Atherosclerosis Suppls 11(2): 138-139 (2010)

Ms150 Basement Membrane Adaptations in Critical Limb Ischaemia
, Atherosclerosis Suppls 11(2): 139-140 (2010)

Ms155 to Determine Circulating Visfatin Levels in Patients with Myocardial Infarction and its Relationship with the Severity of Stenosis
, Atherosclerosis Suppls 11(2): 140-141 (2010)

Ms165 Decreased Expression of Cd39 in Symptomatic Carotid Artery Plaques
, Atherosclerosis Suppls 11(2): 142-143 (2010)

Ms170 Low-Fluence Pdt Impairs Phagocytic Activity of Human Macrophages
, Atherosclerosis Suppls 11(2): 143-144 (2010)

Ms185 Tf and Tfpi Polymorphisms in Coronary Heart Disease and Diabetes type 2
, Atherosclerosis Suppls 11(2): 146-147 (2010)

Ms194 the Influence of Apolipoprotein e Genetic Variants on Serum Lipids and Insulin Resistance in Tarf Study
, Atherosclerosis Suppls 11(2): 148-149 (2010)

Ms199 Impact of Maternal and Paternal History of Premature Myocardial Infarction on the Age of Manifestation of Acute Coronary Syndrome
, Atherosclerosis Suppls 11(2): 149-150 (2010)

Ms204 Eccentric Endurance Exercise Significantly Improves Fasting Glucose and Glucose Tolerance in Non-Diabetic Subjects
, Atherosclerosis Suppls 11(2): 150-151 (2010)

Ms209 New Event of Myocardial Infarction (Mi) in Patients with past Mi: Age, Sex and Treatment Differences
, Atherosclerosis Suppls 11(2): 151-152 (2010)

Ms239 Adipose Tissue Inflammatory Activity is Associated with Cardiovascular Disease
, Atherosclerosis Suppls 11(2): 157-158 (2010)

Ms244 the Prevalence of Masked Hypertension in Treated type 2 Diabetic Patients and its Association with Cardiovascular Target Organ Damage
, Atherosclerosis Suppls 11(2): 158-159 (2010)

Ms249 Association Of The Q223R Polymorphism In The Leptin Receptor Gene With Age At Menarche
, Atherosclerosis Suppls 11(2): 159-160 (2010)

Ms254 Monocyte Chemoattractant Protein 1 (Mcp-1): The Link between Obesity and Atherosclerosis?
, Atherosclerosis Suppls 11(2): 160-161 (2010)

Ms259 Relationship of Inflammatory Marker C-Reactive Protein, Lipid Markers and Conventional Cardiovascular Risk Factors in Subjects with Suspected Coronary Artery Disease
, Atherosclerosis Suppls 11(2): 161-162 (2010)

Ms264 Framingham And Procam Score Plus Cd44L Show Strong Association Of Periodontal Disease Score
, Atherosclerosis Suppls 11(2): 162-163 (2010)

Ms274 Risk Factor Differences Predisposing to Recurrence And/Or Death in Young Early Onset Coronary Artery Disease Patients
, Atherosclerosis Suppls 11(2): 164-165 (2010)

Ms279 in Applicability of the Cardiovascular Risk Predictor Score to Patients with Familial Hypercholesterolemia (Fh)
, Atherosclerosis Suppls 11(2): 165-166 (2010)

Ms284 the Frequency and Prevalence of the Coronary Heart Disease in Patients with Metabolic Syndrome
, Atherosclerosis Suppls 11(2): 166-167 (2010)

Ms294 Most Important Cardiovascular Risk Factors in Prognosis of Patients with Myocardial Infarction 5 Year Follow up Study
, Atherosclerosis Suppls 11(2): 168-169 (2010)